var title_f12_13_12496="Dorsal hood splint";
var content_f12_13_12496=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal hood splint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dorsal hood splint is used to immobilize the thumb for disorders such as carpometacarpal joint osteoarthritis, de Quervain's tenosynovitis, trigger thumb, gamekeeper's thumb, etc...",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12496=[""].join("\n");
var outline_f12_13_12496=null;
var title_f12_13_12497="Calculator: In-Flight PaO2 Estimation (using PFT's)";
var content_f12_13_12497=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"InFlightPaO2PFTs_form\" name=\"InFlightPaO2PFTs_form\" onkeydown=\"clrResults();\" onkeyup=\"InFlightPaO2PFTs_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: In-Flight PaO2 Estimation (using PFT's)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"      <tr>",
"       <td align=\"left\" bgcolor=\"#6c9a9c\">",
"        <span class=\"medCalcFontFormuli\">",
"         PaO2 = 22.26 + (0.238 * SeaLevelPaO2) + (20.1 * FEV1 / FVC)",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"      <tr>",
"       <td align=\"right\" width=\"50%\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Input:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Sea Level PaO2",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Sea_Level_PaO2_param\" onblur=\"InFlightPaO2PFTs_fx(); minMaxCheck();\" onchange=\"InFlightPaO2PFTs_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Sea_Level_PaO2_unit\" onchange=\"InFlightPaO2PFTs_fx();\" style=\"width:105px;\">",
"             <option value=\"10|0|cmHg\">",
"              cmHg",
"             </option>",
"             <option selected=\"selected\" value=\"1|0|mmHg\">",
"              mmHg",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             FEV1",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"FEV1_param\" onblur=\"InFlightPaO2PFTs_fx(); minMaxCheck();\" onchange=\"InFlightPaO2PFTs_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"FEV1_unit\" onchange=\"InFlightPaO2PFTs_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|L\">",
"              L",
"             </option>",
"             <option value=\"0.001|0|mL\">",
"              mL",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             FVC",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"FVC_param\" onblur=\"InFlightPaO2PFTs_fx(); minMaxCheck();\" onchange=\"InFlightPaO2PFTs_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"FVC_unit\" onchange=\"InFlightPaO2PFTs_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|L\">",
"              L",
"             </option>",
"             <option value=\"0.001|0|mL\">",
"              mL",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Result:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             PaO2",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"PaO2_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td valign=\"top\">",
"            <span class=\"medCalcFontOne\">",
"             <select class=\"medCalcFontSelect\" name=\"PaO2_unit\" onchange=\"InFlightPaO2PFTs_fx();\" style=\"width:105px;\">",
"              <option value=\"10|0|cmHg\">",
"               cmHg",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mmHg\">",
"               mmHg",
"              </option>",
"             </select>",
"            </span>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td colspan=\"3\">",
"            &nbsp;",
"            <br/>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"center\" colspan=\"3\">",
"            <span class=\"medCalcFontOneBold\">",
"             Decimal Precision:",
"            </span>",
"            <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"InFlightPaO2PFTs_fx();\">",
"             <option>",
"              0",
"             </option>",
"             <option>",
"              1",
"             </option>",
"             <option selected=\"selected\">",
"              2",
"             </option>",
"             <option>",
"              3",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"      </tr>",
"     </table>",
"    </center>",
"    <span class=\"medCalcFontOneBold\">",
"     Notes",
"    </span>",
"    <ul class=\"medCalcFontOne\">",
"     <li>",
"      This equation helps predict a patients",
"      <b>",
"       PaO2",
"      </b>",
"      while in a typical pressurized cabin.",
"     </li>",
"     <li>",
"      This pressure is usually kept at an equivalent of 8000 feet altitude.",
"     </li>",
"    </ul>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <span class=\"medCalcFontRef\">",
"     <b>",
"      References",
"     </b>",
"    </span>",
"    <ol>",
"     <li>",
"      <span class=\"medCalcFontRef\">",
"       Dillard TA, Moores LK, Bilello KL, Phillips YY. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure.",
"       <i>",
"        Chest",
"       </i>",
"       . 1995 Feb;107(2):352-7.",
"      </span>",
"     </li>",
"    </ol>",
"   </form>",
"   <br/>",
"   &nbsp;",
"   <br/>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12497=[" /* <![CDATA[ */",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function InFlightPaO2PFTs_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.InFlightPaO2PFTs_form){",
"",
"",
"doCalc = true;",
"if (Sea_Level_PaO2_param.value.indexOf(',') >= 0){ Sea_Level_PaO2_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Sea_Level_PaO2_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Sea_Level_PaO2_unit.options[Sea_Level_PaO2_unit.selectedIndex].value.split('|');",
"Sea_Level_PaO2 = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (FEV1_param.value.indexOf(',') >= 0){ FEV1_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(FEV1_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = FEV1_unit.options[FEV1_unit.selectedIndex].value.split('|');",
"FEV1 = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (FVC_param.value.indexOf(',') >= 0){ FVC_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(FVC_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = FVC_unit.options[FVC_unit.selectedIndex].value.split('|');",
"FVC = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"PaO2 =  22.26 + (0.238 * Sea_Level_PaO2) + (20.1 * FEV1 / FVC);",
"",
"unit_parts = PaO2_unit.options[PaO2_unit.selectedIndex].value.split('|');",
"if (doCalc) PaO2_param.value = fixDP((PaO2 - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.InFlightPaO2PFTs_form){",
"",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.InFlightPaO2PFTs_form){",
"",
"PaO2_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"/* ]]> */"].join("\n");
var outline_f12_13_12497=null;
var title_f12_13_12498="Cholangioscopy following electrohydraulic lithotripsy";
var content_f12_13_12498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54231&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54231&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cholangioscopy following electrohydraulic lithotripsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cholangioscopy of the bile duct following fragmentation of a bile duct stone using electrohydraulic lithotripsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Yang K Chen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12498=[""].join("\n");
var outline_f12_13_12498=null;
var title_f12_13_12499="Patient information: Labor and delivery (childbirth) (The Basics)";
var content_f12_13_12499=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16907\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/40/18051\">",
"         Vaginal delivery (childbirth)",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"          Female reproductive anatomy",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/45/18131\">",
"           Different baby positions in the uterus",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?17/62/18402\">",
"         Patient information: Breech pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/21/16723\">",
"         Patient information: C-section (cesarean delivery) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/2/4131\">",
"         Patient information: How to tell when labor starts (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/5/33873\">",
"         Patient information: Managing pain during labor and delivery (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/31/31218\">",
"         Patient information: Newborn appearance (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/20/27970\">",
"         Patient information: Preterm labor (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/2/19490\">",
"         Patient information: Shoulder dystocia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/60/20418\">",
"         Patient information: Vaginal birth after cesarean delivery (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/45/11988\">",
"         Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/52/35650\">",
"         Patient information: Preterm labor (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Labor and delivery (childbirth) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/labor-and-delivery-childbirth-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H81825352\">",
"      <span class=\"h1\">",
"       What happens during the delivery of a baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;During delivery, the doctor or midwife will help you give birth to your baby. When a baby comes out of a woman&rsquo;s vagina, it&rsquo;s called a &ldquo;vaginal delivery.&rdquo; When a doctor does surgery to get a baby out of a woman&rsquo;s uterus, it&rsquo;s called a &ldquo;c-section&rdquo; or &ldquo;cesarean delivery.&rdquo;",
"     </p>",
"     <p>",
"      During a vaginal delivery, you will work hard to push your baby out (",
"      <a class=\"graphic graphic_figure graphicRef59831 \" href=\"UTD.htm?17/40/18051\">",
"       figure 1",
"      </a>",
"      ). But before you can push your baby out, a few things need to happen. Your cervix has to soften, thin out, and open up all the way (",
"      <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"       figure 2",
"      </a>",
"      ). Also, your baby has to move from the uterus down the birth canal to the vagina. When this happens, it can feel like you are going to have a bowel movement.",
"     </p>",
"     <p>",
"      Your doctor or midwife will tell you when you can start pushing your baby out. In most cases, you can be in whatever position feels comfortable to you. For example, you can lie on your side, sit up, kneel, or squat. Pushing a baby out can take anywhere from minutes to hours. It usually takes longer when it&rsquo;s a woman&rsquo;s first baby.",
"     </p>",
"     <p>",
"      Most deliveries happen without any problems. But sometimes, babies can get partly stuck in the birth canal. If this happens, your doctor or midwife can help pull your baby out by using a device that holds onto his or her head. If your doctor needs to deliver your baby right away, he or she will do a c-section.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825367\">",
"      <span class=\"h1\">",
"       Does childbirth hurt?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, childbirth usually hurts. But the amount of pain is different for each woman. Women choose to manage their pain in different ways. There is no one way that works for everyone. The right decision is the one that is best for you.",
"     </p>",
"     <p>",
"      Some women choose to have a &ldquo;natural&rdquo; childbirth. This means that they do not use any pain medicines during labor or delivery. Instead, they do other things, such as breathing exercises, to lessen their pain.",
"     </p>",
"     <p>",
"      Other women choose to have medicines to lessen the pain of labor and delivery. If you choose to have pain medicine, your doctor or midwife will probably start giving you the medicine during your labor, before delivery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825382\">",
"      <span class=\"h1\">",
"       What if my baby is not in the right position?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Before birth, babies lie in the uterus in different positions (",
"      <a class=\"graphic graphic_figure graphicRef72643 \" href=\"UTD.htm?17/45/18131\">",
"       figure 3",
"      </a>",
"      ). At the end of pregnancy, most babies lie facing head down, with their head closest to the vagina. But some babies lie with their legs, buttocks, or shoulders closest to the vagina. Doctors call it &ldquo;breech&rdquo; if your baby&rsquo;s legs or buttocks are closest to the vagina.",
"     </p>",
"     <p>",
"      If your baby isn&rsquo;t facing head down, your doctor or midwife will talk with you about your options. He or she might be able to turn your baby before you go into labor and deliver him or her vaginally. Or he or she might suggest that you have a c-section.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825397\">",
"      <span class=\"h1\">",
"       What happens after I give birth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After your baby is born, the placenta also needs to come out of the uterus. The placenta is the organ inside the uterus that brings a baby nutrients and oxygen, and carries away waste. Usually the placenta comes out naturally within 30 minutes of the baby&rsquo;s birth, but sometimes the doctor or midwife has to help remove it from your uterus.",
"     </p>",
"     <p>",
"      After the placenta is out of your uterus, the doctor or midwife will examine your vagina. If your skin tore during birth, you might need some stitches.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825412\">",
"      <span class=\"h1\">",
"       What happens to my baby after birth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After birth, the doctor, nurse, midwife, or pediatrician will do a quick exam to check your baby&rsquo;s body and general health. Part of this exam is called an &ldquo;Apgar test.&rdquo; It checks your baby&rsquo;s heart rate, breathing, movement, muscles, and skin color. Your baby will get Apgar tests at 1 minute and 5 minutes after birth.",
"     </p>",
"     <p>",
"      Soon after birth, you will be able to hold your baby. You can even breastfeed him or her, if you choose to breastfeed.",
"     </p>",
"     <p>",
"      Your baby will get some treatments soon after birth. These include eye drops or an eye ointment to prevent an eye infection, and a dose of vitamin K to prevent abnormal bleeding.",
"     </p>",
"     <p>",
"      Before your baby leaves the hospital, he or she will also have:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A detailed physical exam",
"       </li>",
"       <li>",
"        A blood test (done by a heel prick) to check for different serious diseases that babies can be born with. For more information on this testing, ask your doctor or nurse.",
"       </li>",
"       <li>",
"        A hearing test",
"       </li>",
"       <li>",
"        A dose of the",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?10/38/10849?source=see_link\">",
"         hepatitis B vaccine",
"        </a>",
"        &ndash; Vaccines are treatments that can prevent certain serious infections. Hepatitis B is a serious liver infection.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825427\">",
"      <span class=\"h1\">",
"       When should I call the doctor or nurse after a vaginal delivery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After you leave the hospital, call your doctor or nurse if you:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Bleed a lot from your vagina &ndash; It is normal to have some vaginal bleeding for a few weeks after delivery. But let your doctor or nurse know if you are having large blood clots or your bleeding increases.",
"       </li>",
"       <li>",
"        Feel dizzy or faint",
"       </li>",
"       <li>",
"        Get a fever",
"       </li>",
"       <li>",
"        Vomit",
"       </li>",
"       <li>",
"        Have new belly pain",
"       </li>",
"       <li>",
"        Have a severe headache, problems with your vision, or swelling in your hands or feet",
"       </li>",
"       <li>",
"        Feel sad or helpless",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81825442\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=see_link\">",
"       Patient information: C-section (cesarean delivery) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/20/27970?source=see_link\">",
"       Patient information: Preterm labor (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/5/33873?source=see_link\">",
"       Patient information: Managing pain during labor and delivery (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=see_link\">",
"       Patient information: How to tell when labor starts (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/31/31218?source=see_link\">",
"       Patient information: Newborn appearance (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/2/19490?source=see_link\">",
"       Patient information: Shoulder dystocia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/60/20418?source=see_link\">",
"       Patient information: Vaginal birth after cesarean delivery (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/62/18402?source=see_link\">",
"       Patient information: Breech pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=see_link\">",
"       Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/52/35650?source=see_link\">",
"       Patient information: Preterm labor (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?12/13/12499?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16907 Version 6.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-DCF38A056D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12499=[""].join("\n");
var outline_f12_13_12499=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825352\">",
"      What happens during the delivery of a baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825367\">",
"      Does childbirth hurt?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825382\">",
"      What if my baby is not in the right position?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825397\">",
"      What happens after I give birth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825412\">",
"      What happens to my baby after birth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825427\">",
"      When should I call the doctor or nurse after a vaginal delivery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81825442\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16907\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/40/18051\">",
"      Vaginal delivery (childbirth)",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"       Female reproductive anatomy",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/45/18131\">",
"        Different baby positions in the uterus",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/62/18402?source=related_link\">",
"      Patient information: Breech pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=related_link\">",
"      Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=related_link\">",
"      Patient information: C-section (cesarean delivery) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=related_link\">",
"      Patient information: How to tell when labor starts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/5/33873?source=related_link\">",
"      Patient information: Managing pain during labor and delivery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/31/31218?source=related_link\">",
"      Patient information: Newborn appearance (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/52/35650?source=related_link\">",
"      Patient information: Preterm labor (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/20/27970?source=related_link\">",
"      Patient information: Preterm labor (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/2/19490?source=related_link\">",
"      Patient information: Shoulder dystocia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/60/20418?source=related_link\">",
"      Patient information: Vaginal birth after cesarean delivery (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_13_12500="Prenatal diagnosis of congenital mesoblastic nephroma";
var content_f12_13_12500=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prenatal diagnosis of congenital mesoblastic nephroma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Tulin Ozcan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12500/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/13/12500/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly two thirds of infantile or fetal abdominal masses are of renal origin. Most are benign and related to hydronephrosis and multicystic dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/1\">",
"     1",
"    </a>",
"    ]. Congenital renal tumors are rare, comprising 2.5 to 7 percent of all perinatal tumors. This category includes, in decreasing order of frequency, congenital mesoblastic nephroma, Wilms tumor, rhabdoid tumor, clear cell sarcoma, hamartomas (eg, angiomyolipoma), and ossifying tumor of infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Congenital mesoblastic nephroma (CMN) arises from renal mesenchyma and is usually benign. It comprises less than 5 percent of all pediatric renal tumors. About 90 percent present in the first year of life, 50 to 75 percent of cases occur in young infants, and almost none occur after the age of 3 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/3\">",
"     3",
"    </a>",
"    ]. After 2 months of age, Wilms tumor is more common than CMN. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15737?source=see_link\">",
"     \"Prenatal sonographic diagnosis of cystic renal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2249?source=see_link\">",
"     \"Presentation, diagnosis, and staging of Wilms tumor\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CNM is a solitary hamartoma. Mesoblastic nephroma is presumed to originate from proliferating nephrogenic mesenchyme. It is similar in gross and histologic appearance to a uterine leiomyoma with spindled cell sin bundles, but composed of immature renal stromal cells. The tumor lacks renal blastema and neoplastic metanephric elements, thereby differentiating it from Wilms tumor. In addition, it tends to infiltrate the kidney, rather than form the pseudocapsule of classic Wilms tumor.",
"   </p>",
"   <p>",
"    There are two pathologic variants: classic CMN and atypical or cellular CMN. The classic form is characterized by rare mitoses and absence of necrosis. Dilated vessels and entrapped nephrons are sometimes seen at the periphery of the tumor. Atypical or cellular CMN is characterized by a high mitotic index, hypercellularity, and an atypical growth pattern with necrosis, hemorrhage, and invasion of adjacent structures other than connective tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CNM is almost always unilateral and is rarely malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/5\">",
"     5",
"    </a>",
"    ]. It may extend beyond the renal capsule, but rarely metastasizes to distant organs. Cellular CMN, older age, and positive surgical margins appear to increase the risk of recurrence and metastasis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cytogenetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The translocation t(12;15) (p13;q25) that gives rise to an ETV6-NTRK3 gene fusion is detected in most cellular types. This gene fusion encodes a chimeric tyrosine kinase with potent transforming activity in fibroblasts. This translocation is not present in the classic leiomyomatous type; however, it can occasionally be found in predominantly leiomyomatous mesoblastic nephromas in the small areas of cellular pattern. ETV6-NTRK3 gene fusion also has been observed in congenital fibrosarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/7\">",
"     7",
"    </a>",
"    ], thus forming a genetic link between congenital fibrosarcoma and cellular type of CMN. Cellular or mixed types also appear to present with multiple polysomes and have extra copies of many chromosomes, including 11, 7, 8, 9, 12, 17, and 20 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMN predominates in boys with a male:female ratio of about 2:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/6\">",
"     6",
"    </a>",
"    ]. Clinical features in the perinatal period include polyhydramnios, hematuria, anemia, hypertension, hypercalcemia, and elevated renin levels. Many of these findings are probably due to mass effect and are shared by Wilms tumor.",
"   </p>",
"   <p>",
"    Polyhydramnios accompanies about 70 percent of cases, and contributes to the high rate (25 percent) of premature delivery. The increased amniotic fluid may be attributed to increased urine production due to renal hyperperfusion, decreased gastrointestinal absorption due to bowel compression, or tumor secretion of prostaglandins leading to hypercalcemia induced polyuria [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/9\">",
"     9",
"    </a>",
"    ]. Rarely, fetal hydrops develops secondary to high output failure related to the increased vascularity of the tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common presentation of CMN is an unilateral solid mass with homogeneous echogenicity located near the hilus and involving the renal sinus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/10\">",
"     10",
"    </a>",
"    ]. The tumor lacks a well-defined capsule and blends with the normal renal parenchyma; however, it is well-demarcated from the renal tissue. The tumor moves with the renal parenchyma when fetal breathing movements are detected.",
"   </p>",
"   <p>",
"    CMN is an angiomatous tumor and arteriovenous shunts may be present and reveal Doppler color blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/11\">",
"     11",
"    </a>",
"    ]. A thin hypoechoic rim with venous and arterial Doppler signals has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/12\">",
"     12",
"    </a>",
"    ]. Occasionally, however, CMN appears as a hypoechogenic tumor with an echogenic rim ('Ring sign') [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The earliest detection of mesoblastic nephroma was made at 22 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/14\">",
"     14",
"    </a>",
"    ]. In one series of 20 cases, the origin of the tumor was correctly suspected on prenatal ultrasound examination [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/15\">",
"     15",
"    </a>",
"    ]. The mass usually arose from the kidney (and was indistinguishable from it), from the renal fossa, or from an upper quadrant of the abdomen. Other presentations included an enlarged kidney without a separate renal mass and an abdominal tumor with an absent ipsilateral kidney. Echogenicity of the mass is variable and has been described as homogeneous, heterogeneous, or with small echogenic nodules within the tumor. In one case, it was reported that the outlines of the mass were difficult to define because the echogenicity was similar to that of intestinal loops; external compression on the stomach and the bladder first alerted the operator to the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most renal masses detected in utero are cystic (hydronephrosis, multicystic dysplastic kidney). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15737?source=see_link\">",
"     \"Prenatal sonographic diagnosis of cystic renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of a solid renal mass includes autosomal recessive polycystic kidney disease, diffuse nephroblastomatosis, Beckwith-Wiedemann syndrome with bilateral duplex collecting systems, compensatory hypertrophy with absence of the contralateral kidney, and crossed-fused ectopia.",
"   </p>",
"   <p>",
"    An adrenal mass (eg, neuroblastoma, hemorrhage) may give the impression of an enlarged kidney, as can tumors arising from nearby organs. An adrenal hematoma appears as a suprarenal mass, possibly with calcifications, that is &nbsp;marked by rapid changes in sonographic appearance due to organization of the clot. It can be unilateral or bilateral and is usually detected at term. Rare diagnoses to be considered include rhabdoid tumor and unilateral renal vein thrombosis, which is associated with adrenal hematoma. Magnetic resonance imaging can be helpful for assessing the origin of the abdominal mass if ultrasound is not conclusive [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not possible to differentiate Wilms tumor from CMN based upon prenatal ultrasound findings. Both tumors appear as unilateral, single, solid masses arising from the kidney. Bilateral tumors are usually Wilms tumors; in a study evaluating the outcome of renal tumors in the first seven months of life, 37 out of 39 bilateral tumors were Wilms tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/16\">",
"     16",
"    </a>",
"    ]. By comparison, CMN can have hypoechoic cavitary portions from necrosis or hemorrhage and shows infiltration into the renal tissue, whereas Wilms tumor has a pseudocapsule, and CWN is frequently associated with polyhydramnios.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm labor is common due to uterine distension from polyhydramnios [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. One study including 28 cases (26 mesoblastic nephroma, two Wilms tumors) emphasized the need for delivery in a tertiary care center because of a high risk of perinatal complications (71 percent of the cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/17\">",
"     17",
"    </a>",
"    ]. These complications included: polyhydramnios (11), delivery &lt;34 weeks of gestation (13), hydrops fetalis (2), acute nonreassuring fetal heart rate patterns requiring emergency cesarean delivery (7), and intrauterine fetal death (1). Complications at birth included hemodynamic instability (3), emergency neonatal surgery (2), respiratory distress syndrome (8) and hypertension (6). Other case series have also reported hydrops fetalis, which is usually fatal [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12500/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypertension results from increased renin levels and entrapment of renal parenchyma by the infiltrating fibrous strands. Secretion of prostaglandin or a parathyroid-hormone-like substance can also lead to hypercalcemia.",
"   </p>",
"   <p>",
"    Radical nephrectomy is performed after the end of the first week of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet\">",
"     <li>",
"      Congenital mesoblastic nephroma is an unilateral benign solid tumor that arises from the renal parenchyma. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is the most common renal tumor in the fetus and in the first three months of postnatal life. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Polyhydramnios accompanies about 70 percent of all cases. Rarely, fetal hydrops develops. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common presentation is as an unilateral solid mass with homogeneous echogenicity located near the hilus and involving the renal sinus. The tumor lacks a well-defined capsule and blends with the normal renal parenchyma; however, it is well-demarcated from the renal tissue. Prenatal differentiation from Wilms tumor may not be possible. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Twenty-five percent of cases deliver preterm. The prognosis is excellent with unilateral nephrectomy; however, the cellular type can occasionally metastasize and recur. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Outcome'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/1\">",
"      Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg 2004; 39:522.",
"     </a>",
"    </li>",
"    <li>",
"     Isaac, HJ. Tumors. In: Potter's pathology of the fetus and newborn, vol 2, Gilbert Barnes, E (Ed), Mosby, St Louis, MO 1997. p.1242.",
"    </li>",
"    <li>",
"     Eble, JN, Sauter, G, Epstein, JI, Sesterhenn, IA. Tumours of the urinary system and male genital organs Pathology and genetics. World Health Organization 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/4\">",
"      Joshi VV, Kasznica J, Walters TR. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med 1986; 110:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/5\">",
"      Giulian BB. Prenatal ultrasonographic diagnosis of fetal renal tumors. Radiology 1984; 152:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/6\">",
"      Furtwaengler R, Reinhard H, Leuschner I, et al. Mesoblastic nephroma--a report from the Gesellschaft fur P&auml;diatrische Onkologie und H&auml;matologie (GPOH). Cancer 2006; 106:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/7\">",
"      Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/8\">",
"      Schofield DE, Yunis EJ, Fletcher JA. Chromosome aberrations in mesoblastic nephroma. Am J Pathol 1993; 143:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/9\">",
"      Maymon R, Strauss S, Herman A, et al. The prenatal scan pitfall for the diagnosis of renal mass: case report. Prenat Diagn 2004; 24:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/10\">",
"      Fuchs IB, Henrich W, Brauer M, et al. Prenatal diagnosis of congenital mesoblastic nephroma in 2 siblings. J Ultrasound Med 2003; 22:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/11\">",
"      Goldstein I, Shoshani G, Ben-Harus E, Sujov P. Prenatal diagnosis of congenital mesoblastic nephroma. Ultrasound Obstet Gynecol 2002; 19:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/12\">",
"      Kelner M, Droull&eacute; P, Didier F, Hoeffel JC. The vascular \"ring\" sign in mesoblastic nephroma: report of two cases. Pediatr Radiol 2003; 33:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/13\">",
"      Geller E, Smergel EM, Lowry PA. Renal neoplasms of childhood. Radiol Clin North Am 1997; 35:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/14\">",
"      Chen WY, Lin CN, Chao CS, et al. Prenatal diagnosis of congenital mesoblastic nephroma in mid-second trimester by sonography and magnetic resonance imaging. Prenat Diagn 2003; 23:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/15\">",
"      Irsutti M, Puget C, Baunin C, et al. Mesoblastic nephroma: prenatal ultrasonographic and MRI features. Pediatr Radiol 2000; 30:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/16\">",
"      van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer 2008; 50:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/17\">",
"      Leclair MD, El-Ghoneimi A, Audry G, et al. The outcome of prenatally diagnosed renal tumors. J Urol 2005; 173:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12500/abstract/18\">",
"      Liu YC, Mai YL, Chang CC, et al. The presence of hydrops fetalis in a fetus with congenital mesoblastic nephroma. Prenat Diagn 1996; 16:363.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6751 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-1759BFA714-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12500=[""].join("\n");
var outline_f12_13_12500=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cytogenetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15737?source=related_link\">",
"      Prenatal sonographic diagnosis of cystic renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2249?source=related_link\">",
"      Presentation, diagnosis, and staging of Wilms tumor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_13_12501="US normal T cervix";
var content_f12_13_12501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    US normal T cervix",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal cervix, no funneling (\"T-shaped\"). Note prominent endocervical mucus, small Nabothian cyst near external os. Lower uterine segment (LUS) thick and not developed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey R. Johnson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12501=[""].join("\n");
var outline_f12_13_12501=null;
var title_f12_13_12502="Clinical manifestations and diagnosis of Q fever";
var content_f12_13_12502=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of Q fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Didier Raoult, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12502/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/13/12502/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 6, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Q fever is a widespread zoonotic infection caused by the pathogen Coxiella burnetii that has both acute and chronic manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ]. The designation Q fever (from Query) was made in 1935 following an outbreak of febrile illness in an abattoir in Queensland, Australia. The name remains apt, however, since many questions persist about this special organism and very strange disease. The disease is reportable in the United States and its agent, Coxiella burnetii, is a potential agent of bioterrorism (class B of the CDC) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of Q fever will be reviewed here. The treatment and prevention of Q fever, microbiology and epidemiology of Q fever, and Q fever endocarditis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22357?source=see_link\">",
"     \"Microbiology and epidemiology of Q fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=see_link\">",
"     \"Q fever endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36323?source=see_link\">",
"     \"Treatment and prevention of Q fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical signs of Q fever are often mild or absent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/3\">",
"     3",
"    </a>",
"    ]. As an example, during an outbreak of 415 cases of Q fever in Switzerland, 224 (54 percent) were asymptomatic and only 2 percent were hospitalized [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/4\">",
"     4",
"    </a>",
"    ]. The factors that determine whether or not symptoms develop are not well understood. Symptomatic infection is more likely in adults compared with children and in men compared with women [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/5\">",
"     5",
"    </a>",
"    ]. The genotype of the organism also may be important [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptomatic illness can be divided into acute and chronic forms. Chronic Q fever is defined as infection lasting for more than six months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Features during an outbreak",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of Q fever infection was illustrated in an outbreak of Q fever in the French Alps in 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/5\">",
"     5",
"    </a>",
"    ]. Extensive surveillance was conducted to describe variations in clinical expression of acute infection in relation to host factors and to monitor the evolution of acute to chronic infection in patients at risk (376 pregnant women), 91 patients with cardiac disease (mostly valvular disease), and 19 immunocompromised patients. A group of 578 individuals without risk factors for progression were also monitored. The diagnosis of Q fever was based upon serologic testing by immunofluorescence assay. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Serology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among serum samples from over 1000 individuals, acute Q fever was diagnosed serologically in 101 (9.3 percent).",
"     </li>",
"     <li>",
"      Acute Q fever occurred in 2.6 percent of pregnancies, 5.5 percent of patients with valvular heart disease, and 14.7 percent of individuals without risk factors (28 percent of symptomatic and 4 percent of asymptomatic individuals).",
"     </li>",
"     <li>",
"      The rate of clinical expression was 91 percent in adult men, 75 percent in adult women, 33 percent in children, and only 9 percent in pregnant women.",
"     </li>",
"     <li>",
"      Among the 101 patients with acute Q fever, evolution to chronic infection occurred in five (5 percent and 0.5 percent of the entire screened population).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acute infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period for acute infection is approximately 20 days (range 14 to 39) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/4\">",
"     4",
"    </a>",
"    ]. While the manifestations may be protean, three clinical presentations are typically encountered [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A self-limited flu-like illness",
"     </li>",
"     <li>",
"      Pneumonia",
"     </li>",
"     <li>",
"      Hepatitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the largest collected series of cases, 1383 Q fever patients were identified in France from positive serum specimens submitted to a reference laboratory over a 14-year period; 77 percent of cases were acute [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/7\">",
"     7",
"    </a>",
"    ]. Forty percent of the patients with acute Q fever had hepatitis, 20 percent pneumonia plus hepatitis, 17 percent pneumonia, and 17 percent fever alone. Hepatitis tended to be found in younger patients and pneumonia in older patients who were immunocompromised.",
"   </p>",
"   <p>",
"    The clinical presentation appears to vary with the geographic origin of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, pneumonia is more common than hepatitis in eastern Canada, while pneumonia is rare in southern Spain where hepatitis is very common. In southern France, pneumonia is common and hepatitis very common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Flu-like illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;A self-limited flu-like syndrome is the most common manifestation of Q fever. In Spain, this form of the illness accounts for 21 percent of all febrile episodes lasting from one to three weeks. The onset is typically abrupt with high-grade fever (104&ordm;F or 40&ordm;C), fatigue, headache, and myalgias the most frequent symptoms. Chest radiographs are usually normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;While a flu-like illness is the most common, pneumonia is one of the forms most likely to be recognized as acute Q fever. Pneumonia is the most common manifestation of acute Q fever in Nova Scotia, the Basque region of Spain, and Switzerland. In Nova Scotia, community-acquired pneumonia due to C. burnetii accounted for 7 percent of cases admitted to a tertiary care teaching hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ]; a similar prevalence of 6 percent was found in Israel. Most cases are mild, with a non-productive cough, fever, and minimal auscultatory abnormalities; however, some patients present with acute respiratory distress. Pleural effusion can also occur. Findings on the chest radiograph are not specific and resemble a viral pneumonia. Symptoms can last from 10 to 90 days with a mortality rate from 0.5 to 1.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis can occur in three forms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Similar to infectious hepatitis due to viruses, with hepatomegaly but seldom jaundice",
"     </li>",
"     <li>",
"      Clinically asymptomatic hepatitis with fever and an increase in serum transaminases",
"     </li>",
"     <li>",
"      Prolonged fever of unknown origin with characteristic granulomas on liver biopsy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Q fever hepatitis typically has a granulomatous pathology, in which some of the granulomas appear to be \"doughnut-like\" because they contain a lipidic vacuole surrounded by a fibrinoid ring [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Q fever endocarditis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=see_link\">",
"     \"Q fever endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, Q fever endocarditis usually occurs in patients with previous valvular damage or immunocompromise and, as noted below, is often the predominant manifestation of chronic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/7\">",
"     7",
"    </a>",
"    ]. It has been estimated that acute Q fever in patients with valvular disease, particularly a bicuspid aortic valve or a prosthetic valve, results in endocarditis in approximately 40 percent of patients unless proper treatment is instituted [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/9\">",
"     9",
"    </a>",
"    ]. Some patients who develop Q fever endocarditis have clinically silent and previously undiagnosed valve disease; as a result, screening echocardiography and, if positive, antimicrobial prophylaxis may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other manifestations of acute Q fever include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maculopapular or purpuric rash (10 percent)",
"     </li>",
"     <li>",
"      Pericarditis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      myocarditis (1 percent)",
"     </li>",
"     <li>",
"      Severe headache, aseptic meningitis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      encephalitis (1 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Myocarditis, though uncommon, may be a particularly severe manifestation of Q fever. In one series of 1276 patients with Q fever over a 15-year period, only eight developed myocarditis but two were among only 12 total patients with Q fever who died [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other rare features include seizures, coma, polyradiculoneuritis, optic neuritis, hemophagocytosis, hemolytic anemia, transient hypoplastic anemia, thyroiditis, gastroenteritis, pancreatitis, lymphadenopathy mimicking lymphoma, erythema nodosum, bone marrow necrosis, inappropriate secretion of antidiuretic hormone, mesangioproliferative glomerulonephritis related to antiphospholipid antibodies, orchitis, epididymitis, and splenic rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/13\">",
"     13",
"    </a>",
"    ]. Acute acalculous cholecystitis is another rare manifestation of Q fever; a case series of nine patients reported positive serologies for Q fever and response to antibiotics and laparoscopic cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Chronic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic Q fever is defined as infection lasting for more than six months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"     1",
"    </a>",
"    ]. It occurs in approximately 1 to as many as 5 percent of patients infected with C. burnetii (symptomatic or not) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/14\">",
"     14",
"    </a>",
"    ] and may develop insidiously months or years after the acute disease, especially in patients with underlying diseases. In the large retrospective study cited above, 23 percent had chronic Q fever and endocarditis was the predominant manifestation in 77 percent of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Endocarditis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=see_link\">",
"     \"Q fever endocarditis\"",
"    </a>",
"    .) The second, more common manifestation is vascular aneurysm and prosthesis infection with a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this form of Q fever, C. burnetii multiplies in macrophages and produces a prolonged rickettsemia; the resulting high levels of antibodies and immune complexes directed at the organism contribute to most of the symptoms. The organ most commonly affected is the heart, followed by the arteries, bones, and liver.",
"   </p>",
"   <p>",
"    Other manifestations of chronic Q fever include infection of aneurysms or vascular grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/15\">",
"     15",
"    </a>",
"    ], isolated hepatitis possibly complicated by hepatic fibrosis and cirrhosis, osteoarthritis, and osteomyelitis. Rare cases have been reported in the literature of pericardial effusion, pulmonary interstitial fibrosis, pseudotumor of the lung, lymphoma-like presentation, amyloidosis, and mixed cryoglobulinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/1,13\">",
"     1,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Q fever in pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute Q fever in pregnant women is significantly more asymptomatic than in other patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/5\">",
"     5",
"    </a>",
"    ]. Infection during pregnancy often results in chronic Q fever with rapid appearance of high-level antiphase I IgG and fixation. In animal models, C. burnetii undergoes reactivation during pregnancy and is responsible for abortion, prematurity and low birth weight.",
"   </p>",
"   <p>",
"    During pregnancy, Q fever may result in obstetrical complications, such as spontaneous abortion, intrauterine growth retardation, intrauterine fetal death, oligoamnios, and premature delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. A retrospective study of 53 pregnant women with Q fever was significant for the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      C. burnetii infection during the first trimester was associated with an increased risk of obstetric complications and maternal chronic Q fever compared to infection in later trimesters.",
"     </li>",
"     <li>",
"      Long-term duration (35 days) of cotrimoxazole treatment protected against maternal chronic Q fever infection, placental infection, and obstetric complications, particularly intrauterine fetal death.",
"     </li>",
"     <li>",
"      A strong association was found between placental infection and obstetric complications, including intrauterine fetal death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although intrauterine transmission of C. burnetii has been documented, the consequences of congenital Q fever remain to be determined [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the high rate of asymptomatic infection in pregnant women, it has been suggested that systemic testing for Q fever should be performed during pregnancy in areas where Q fever is prevalent and when a pregnant woman is febrile or has an abnormal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/5\">",
"     5",
"    </a>",
"    ]. One study in India demonstrated that the prevalence of C. burnetii infection in women presenting with a spontaneous abortion was approximately 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory findings during acute Q fever are nonspecific. The diagnosis is usually made by serology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     General laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leukocyte count is usually normal but may be elevated in 25 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ]. The erythrocyte sedimentation rate might also be high. Thrombocytopenia is noted in 25 percent of cases. Liver enzymes are elevated in as many as 85 percent of cases. The increase in transaminases is usually moderate, ranging from 2 to 10 times normal values. During an episode of prolonged fever, the combination of a normal WBC, thrombocytopenia, and elevated hepatic enzymes should raise the diagnosis of Q fever. Creatine phosphokinase is also increased in 20 percent of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Autoantibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoantibodies are frequently found in Q fever although their significance is still unknown. Antimitochondrial antibodies, anti-smooth muscle antibodies and antibodies to phospholipids, especially anticardiolipin antibodies or lupus anticoagulant, have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymerase chain reaction (PCR) has been successfully employed to detect DNA in both cell cultures and clinical samples [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ]. Initially, methods used specific hybridization of labeled DNA probes to nucleic acid amplified from clinical samples. These methods were very sensitive and specific and may be applied to pharyngeal swabs (unpublished data). The determination of primers derived from genes specific to C. burnetii has allowed a simple and reliable method for the detection of this bacterium, even in paraffin-embedded tissues.",
"   </p>",
"   <p>",
"    In our laboratory, we routinely use primers derived from the htpAB-associated repetitive element, which produces a very sensitive PCR-based test since this element exists in at least 19 copies in the C. burnetii Nine Mile I genome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ]. Using a close nested PCR assay, we showed that it is useful to test patients with acute infection when they have no antibody, or low-level antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/21\">",
"     21",
"    </a>",
"    ]. A rapid nested-PCR assay using serum as a template and the Light-Cycler as a thermal cycler (LCN-PCR) might enable the early diagnosis of Q fever endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, PCR testing is also helpful in confirming the serologic diagnosis of chronic infection in patients who have persistent elevations of IgG anti-phase I titers (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Serology'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. burnetii must be cultured in biosafety level 3 containment due to its extreme infectivity. The microorganism has been isolated by inoculation of specimens into conventional cell cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;An immunofluorescence assay (IFA) is the current reference method for the serodiagnosis of Q fever. It is the simplest and one of the most accurate serologic techniques. Screening is performed with anti-phase II anti-immunoglobulins at a serum dilution of 1:50. Positive sera are then serially diluted and tested for the presence of anti-phase I and anti-phase II IgG, IgM, and IgA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22357?source=see_link&amp;anchor=H2#H2\">",
"     \"Microbiology and epidemiology of Q fever\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Seroconversion is usually detected 7 to 15 days after the onset of clinical symptoms. Approximately 90 percent of patients have detectable antibodies by the third week [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ]. A titer &ge;200 for IgG and &ge;50 for IgM against phase II indicate a recent Q fever infection, while an IgG titer &gt;800 against phase I suggests chronic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IFA titers usually reach their maximum levels four to eight weeks after the onset of acute Q fever and then decrease gradually over the following 12 months. The persistence of high levels of anti-phase I antibodies six months after completion of treatment, or the reappearance of antibodies may signal the development of chronic infection.",
"   </p>",
"   <p>",
"    Patients at high risk, such as those with valvular or vascular abnormalities, and specifically with valvular prosthesis, those who are immunodeficient, or pregnant women should undergo repeated C. burnetii serology testing, if they have either a medical history of acute Q fever, or have suffered a prolonged and unexplained febrile episode. When acute Q fever is diagnosed in such a high-risk individual, an IFA test should be repeated monthly for at least six months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26082552\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Q fever is a widespread zoonotic infection caused by the pathogen Coxiella burnetii that has both acute and chronic manifestations. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic illness can be divided into acute and chronic forms. Chronic Q fever is defined as infection lasting for more than six months. Acute infection with Coxiella burnetii is characterized by a self-limited flu-like illness, pneumonia, and hepatitis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Acute infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic Q fever is defined as infection lasting for more than six months. This form of infection occurs in approximately 5 percent of patients infected with C. burnetii and may develop insidiously over months or years following the initial infection, usually manifested as endocarditis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Chronic infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During pregnancy, Q fever may result in obstetrical complications, such as spontaneous abortion, intrauterine growth retardation, intrauterine fetal death, oligoamnios, and premature delivery. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Q fever in pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The laboratory findings during acute Q fever are nonspecific. The diagnosis is usually made by serologic testing with an immunofluorescence assay (IFA). The height of the serologic titers and the class of antibody produced determines whether a patient had acute or chronic infection. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/1\">",
"      Raoult D, Marrie T. Q fever. Clin Infect Dis 1995; 20:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/2\">",
"      Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005; 5:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/3\">",
"      Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008; 83:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/4\">",
"      Dupuis G, Petite J, P&eacute;ter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol 1987; 16:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/5\">",
"      Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 2007; 44:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/6\">",
"      Glazunova O, Roux V, Freylikman O, et al. Coxiella burnetii genotyping. Emerg Infect Dis 2005; 11:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/7\">",
"      Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/8\">",
"      Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol 1998; 36:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/9\">",
"      Fenollar F, Fournier PE, Carrieri MP, et al. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001; 33:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/10\">",
"      Fenollar F, Thuny F, Xeridat B, et al. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis 2006; 42:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/11\">",
"      Bernit E, Pouget J, Janbon F, et al. Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002; 162:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/12\">",
"      Fournier PE, Etienne J, Harle JR, et al. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 2001; 32:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/13\">",
"      Marrie TJ, Raoult D. Q fever--a review and issues for the next century. Int J Antimicrob Agents 1997; 8:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/14\">",
"      Rolain JM, Lepidi H, Harl&eacute; JR, et al. Acute acalculous cholecystitis associated with Q fever: report of seven cases and review of the literature. Eur J Clin Microbiol Infect Dis 2003; 22:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/15\">",
"      Fournier PE, Casalta JP, Piquet P, et al. Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review. Clin Infect Dis 1998; 26:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/16\">",
"      Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002; 162:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/17\">",
"      Carcopino X, Raoult D, Bretelle F, et al. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007; 45:548.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/ncidod/dvrd/qfever/index.htm#prevention1 (Accessed on March 03, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/19\">",
"      Stein A, Raoult D. Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis 1998; 27:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/20\">",
"      Vaidya VM, Malik SV, Kaur S, et al. Comparison of PCR, immunofluorescence assay, and pathogen isolation for diagnosis of q fever in humans with spontaneous abortions. J Clin Microbiol 2008; 46:2038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/21\">",
"      Fournier PE, Raoult D. Comparison of PCR and serology assays for early diagnosis of acute Q fever. J Clin Microbiol 2003; 41:5094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12502/abstract/22\">",
"      Fenollar F, Fournier PE, Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol 2004; 42:4919.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5523 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12502=[""].join("\n");
var outline_f12_13_12502=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26082552\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Features during an outbreak",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acute infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Flu-like illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Hepatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Chronic infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Q fever in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      General laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Autoantibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26082552\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22357?source=related_link\">",
"      Microbiology and epidemiology of Q fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=related_link\">",
"      Q fever endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36323?source=related_link\">",
"      Treatment and prevention of Q fever",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_13_12503="ME cholesteatoma removal";
var content_f12_13_12503=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F58365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F58365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Removal of a cholesteatoma in the middle ear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 534px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) Canal incisions for a middle ear exploration to remove a congenital cholesteatoma. Panel B) The ear canal and half the drum are turned down as a flap to expose the cholesteatoma beneath the malleus; usually the drum is left attached to the end of the malleus. Panel C) The cholesteatoma is detached from its mucosal connections and delivered intact. The drum is then returned to its normal anatomic position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Panels A and B courtesy of Glenn C Isaacson, MD, FAAP, FACS. Panel C reproduced with permission from: Isaacson G. Diagnosis of pediatric cholesteatoma. Pediatrics 2007; 120:603. Copyright &copy; 2007 by the AAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12503=[""].join("\n");
var outline_f12_13_12503=null;
var title_f12_13_12504="Depression, mania, and schizophrenia in HIV-infected patients";
var content_f12_13_12504=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Depression, mania, and schizophrenia in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Andrew A Pieper, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Glenn J Treisman, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Jonathan M Silver, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12504/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12504/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/13/12504/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuropsychiatric disorders are common in individuals infected with the human immunodeficiency virus (HIV), based upon a wide variety of factors that include direct effects of the virus preexisting psychiatric conditions, personality vulnerabilities, affective disorders, addictions, or responses to the social isolation and disenfranchisement that are frequently associated with the diagnosis of HIV. Adding to the complexity, many HIV-infected persons have difficulty with treatment adherence due to their behavior patterns as well as specific neuropsychiatric disorders associated with HIV disease progression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, more recent findings have demonstrated that identification and treatment of psychiatric disorders in AIDS patients increases their likelihood of being prescribed highly active antiretroviral therapy (HAART) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/2\">",
"     2",
"    </a>",
"    ]. Among a cohort of patients with AIDS at an HIV clinic offering onsite psychiatric services, individuals receiving treatment for a psychiatric disorder were twice as likely to receive HAART for at least six months compared to those who were not diagnosed with a psychiatric disorder (adjusted odds ratio 2.14, CI 1.37). Prescription of HAART was also associated with a 40 percent reduction in mortality compared to patients without a psychiatric disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HIV-associated depression, mania, and schizophrenia will be reviewed here. An overview of the range of neuropsychiatric conditions associated with HIV infection and more detailed reviews of other specific conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5831?source=see_link\">",
"     \"Overview of the neuropsychiatric aspects of HIV infection and AIDS\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=see_link\">",
"     \"Substance abuse and addiction in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MAJOR DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid depression is common with HIV disease beyond its association with HIV dementia, and depression hinders effective treatment of HIV-infected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/3\">",
"     3",
"    </a>",
"    ]. Prevalences for major depression among patients with HIV and AIDS have been estimated to be between 15 and 40 percent, far exceeding that seen in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/4\">",
"     4",
"    </a>",
"    ]. Major depression increases the risk of acquiring HIV through intensification of substance abuse and exacerbation of self-destructive behaviors, such as exposure to an increased number of sexual partners and lack of condom use [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients with major depression are also at increased risk for HIV disease progression and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HIV increases risk of developing depression through direct damage to subcortical brain areas, chronic stress, worsening social isolation, and intense demoralization. Since depression is underdiagnosed and under-treated in medical clinics it has become one of the most significant factors in the",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    epidemic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of major depression in HIV-infected patients is complicated by the high frequency of depressive symptoms associated with chronic illness, personal loss and isolation, medical treatments that alter mental function, comorbid neurologic illnesses, and comorbid substance abuse. HIV-associated dementia and other HIV-related CNS conditions can produce a flat, apathetic state often misdiagnosed as depression. In turn, the differential diagnosis in HIV patients reporting depressive symptoms includes major depression, dysthymia, dementia, delirium, demoralization, intoxication, withdrawal, CNS injury, CNS infection, and acute medical illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Populations at risk for HIV infection already have inherent elevated rates of major depression, and depression is considered to be a risk factor for HIV transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/4,8\">",
"     4,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of major depression among HIV-infected patients is difficult to measure and has ranged from 15 to 40 percent in different studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. A meta-analysis of 10 studies comparing HIV-positive and at-risk HIV-negative patients demonstrated a twofold increase in the prevalence of major depression among HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/11\">",
"     11",
"    </a>",
"    ], supporting these earlier findings. However, the results of the meta-analysis continue to be debated due to methodologic difficulties in comparing studies that lack a unified definition of depression.",
"   </p>",
"   <p>",
"    The risk of major depression also appears to increase with progression of the HIV infection. For example, the Multicenter AIDS Cohort Study demonstrated a 2.5-fold increase in rates of depression in patients as they develop AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Etiologies of major depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-related infections or malignancy (eg, central nervous system (CNS) toxoplasmosis, cryptococcal meningitis, lymphoma, or syphilis) may also cause depressive symptoms, and several of these conditions have been associated with the development of major depression. Significant rates of depressive symptoms among male HIV-infected patients may also be associated with low testosterone levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/50/22312?source=see_link\">",
"     \"Pituitary and adrenal gland dysfunction in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many of the medications used in HIV patients may produce major depression or depressive syndromes. These include:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    , interferon,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    , sulfonamides, anabolic steroids, corticosteroids and muscle-relaxants. In these cases depression often responds to withdrawal of the offending drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardinal features of depression in HIV-infected patients include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Decrease in mood, vital sense, and self attitude",
"     </li>",
"     <li>",
"      Anhedonia (decrease in pleasure, satiation, satisfaction, or enjoyment from activities)",
"     </li>",
"     <li>",
"      Neurovegetative features (changes in sleep, appetite, or somatic body functions)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unlike the depressive syndrome in HIV-associated dementia, HIV patients with major depression typically report feeling sad in addition to appearing flat in affect. They often report feeling miserable, anxious, worried, angry, upset, or irritable. Mood may vary throughout the day, frequently worse in the morning and better in the afternoon, although other patterns may exist.",
"   </p>",
"   <p>",
"    These patients frequently report anhedonia, defined as suppression of the sense of pleasure or reward that is normally associated with many life behaviors. Such behaviors include those driven by appetite (eg, sleeping, eating, and sex) or those associated with functioning (eg, work, hobbies, dress, social activity, and artistic expression). In the anhedonic state, normal responsiveness to personal enjoyment or positive reinforcement related to activities and experiences of life is blunted or absent. Vital sense, a subjective perception of well being, is also usually diminished in patients with major depression. Afflicted individuals may report that they are sick, feel a sense of heavy pressure in their chest, have low energy, or are even dying. Patients may feel guilty or concerned that they are bad or evil, that they do not deserve the things they have or that they have failed those whom they care about.",
"   </p>",
"   <p>",
"    Another cardinal feature of major depression is neurovegetative symptoms, such as difficulties with sleep, appetite, concentration, and memory. Sleep disturbances may include insomnia or hypersomnia, and patients usually experience early morning awakening with difficulty falling back to sleep. Appetite may be either increased or decreased, and patients often complain that food has lost its flavor. Impairments in concentration and short-term memory may manifest as slowed thought processes or generalized confusion. Major depression is a leading cause of suicide, and every patient must be carefully evaluated for suicidal thoughts or feelings [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HIV-infected patients with depression often present initially to internists and family practitioners with multiple non-specific somatic symptoms, such as headache, gastrointestinal (GI) disturbances, inexplicable musculoskeletal or visceral pain, cardiac symptoms, light-headedness, vertigo, tinnitus, weakness, and anesthesia. Fatigue is associated with depression rather than HIV disease progression, as worsening fatigue and insomnia at six-month follow-up is highly correlated with worsening depression but not CD4 count, change in CD4 count, or HIV disease progression. Thus, multiple nonspecific somatic symptoms in HIV patients should prompt a full psychiatric evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the mainstay of treatment is pharmacologic, psychotherapy also plays a critical role in effective treatment of major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pharmacologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients with major depression respond to antidepressant medication similarly to other patients with major depression. A meta-analysis of five randomized trials (425 patients) found that response (50 percent or greater decrease in baseline depression rating scale score) occurred in more patients who received an antidepressant, compared with placebo (62 versus 37 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/16\">",
"     16",
"    </a>",
"    ]. It does not appear that any particular antidepressant is superior for HIV-infected patients. However, both the side effect profile of the antidepressant and possible interactions with antiretroviral drugs need to be considered in the selection of an agent for treatment of depression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most important component of drug treatment is patient adherence, which is highly influenced by side effects experienced during treatment. The best strategy is to start at low medication doses and slowly titrate up to a therapeutic dose in order to minimize early side effects that may act as obstacles to adherence. After achieving a therapeutic dosage or serum level, patients should be encouraged to wait as long as six to eight weeks for therapeutic effect.",
"   </p>",
"   <p>",
"    Adherence to antiretroviral treatment has also been demonstrated to be higher in depressed patients who are prescribed and adherent to antidepressant medication, compared to patients who are neither prescribed nor adherent to these medications [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Thus routine assessment for depression and prompt pharmacologic treatment is essential to optimize treatment of HIV patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Dose and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The doses of antidepressants that are used for patients with HIV disease and the side effects that can occur are described in the tables (",
"    <a class=\"graphic graphic_table graphicRef70410 \" href=\"UTD.htm?16/35/16945\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef62488 \" href=\"UTD.htm?37/46/38639\">",
"     table 2",
"    </a>",
"    ). Agents whose side-effect profiles are least likely to exacerbate a patient's HIV clinical status should be used first. For example, medications associated with increased GI motility should be avoided as much as possible in patients suffering from chronic diarrhea. Side effects should be assessed at every visit and treated aggressively. Insomnia, a common side effect of selective serotonin reuptake inhibitors (SSRIs), often responds well to low doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    (25 to 150 mg) at bedtime. Constipation from tricyclic antidepressants can be addressed by increased water and fiber intake.",
"   </p>",
"   <p>",
"    Sexual side effects from SSRIs are common; male impotence may be treated with phosphodiesterase-5 (PDE-5) inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/40/21127?source=see_link\">",
"     vardenafil",
"    </a>",
"    ), and other approaches are available for decreased libido and delayed orgasm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2039?source=see_link\">",
"     \"Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Drug interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant interactions can occur between antidepressant medications and drugs used in highly active antiretroviral therapy (HAART) (",
"    <a class=\"graphic graphic_table graphicRef70410 \" href=\"UTD.htm?16/35/16945\">",
"     table 1",
"    </a>",
"    ). While the clinical significance of these possible interactions remains unclear in many cases, these interactions can increase or decrease serum concentrations of either the antidepressant or the antiretroviral drug, thereby heightening side effects or decreasing the efficacy of either agent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/17\">",
"     17",
"    </a>",
"    ]. Potential drug interactions should be taken into consideration when selecting an antidepressant or antipsychotic agent for a patient receiving HAART. For example, a low dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    , a potent inhibitor of CYP3A4 metabolism, is used commonly to boost serum concentrations of the HIV protease inhibitors, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/31/506?source=see_link\">",
"     atazanavir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link&amp;anchor=H9#H9\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\", section on 'Pharmacokinetic boosting with ritonavir'",
"    </a>",
"    .)&nbsp;Ritonavir can thereby increase levels of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    and most tricyclic antidepressants, and thus increase side effects of these drugs. When trazodone or a tricyclic antidepressant is used in combination with a ritonavir-boosted protease inhibitor regimen, the lowest dose of antidepressant should be used initially and adjusted based on clinical assessment and serum drug concentrations, where available [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, depression is associated with non-adherence to HAART; thus, untreated depression may be even more detrimental to progression of HIV than medication interactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Augmentation strategy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who show only partial response to antidepressant medication should be offered an augmentation strategy. The best-studied agent for antidepressant augmentation is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , but its side-effect profile often prevents its use in medically ill HIV-infected patients.",
"   </p>",
"   <p>",
"    A number of other agents may be used to augment antidepressants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=see_link\">",
"     \"Treatment of resistant depression in adults\"",
"    </a>",
"    .) As an example, thyroid preparations, especially triiodothyronine, may benefit patients complaining of fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. Other augmentation agents include other antidepressants or mood stabilizers,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    , benzodiazepines, sleep deprivation, and bright light therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Changing drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;If augmentation fails or the treatment must be abandoned due to intolerable side effects, treatment should be initiated with an entirely new agent. It is important to remember that although medications within the same class may produce similar side effects, a therapeutic response may be seen with one drug even when no response is seen with another drug in the same class.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Psychotherapeutic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with medication plus psychotherapy is likely to be more effective than either modality alone. Psychotherapy also provides a framework for the provider-patient relationship by enabling patients to take control of their lives, which is crucial to successful treatment. Among the individual psychotherapies, interpersonal psychotherapy and cognitive-behavioral psychotherapy have the best evidence to support their efficacy in the treatment of major depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Supportive psychotherapy often helps patients with HIV disease and major depression that have interpreted their suffering as a reaction to the diagnosis or morbidity of HIV infection. Because these individuals may believe that they should be able to pull themselves out of depression without psychiatric treatment, they can become frustrated and further demoralized as they expend significant effort with little benefit. These patients may benefit from education about the disease nature of their depression, encouragement to continue treatment, and therapeutic optimism that psychiatric treatment will ultimately be beneficial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MANIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mania occurs in HIV-infected patients both as a component of bipolar illness and as a unique entity known as AIDS mania. Although manic episodes are associated with increased substance abuse and impulsive behavior, no studies have established that bipolar illness directly increases the risk of acquiring HIV infection. Methodologic barriers to studying this phenomenon, however, have made these studies difficult.",
"   </p>",
"   <p>",
"    Bipolar illness is broad in spectrum, ranging from a severely crippling and chronic mental illness to a mild disorder with alternating experiences of elevated and depressed mood. It is thus difficult to accurately measure the prevalence and incidence of bipolar disorder, which would be necessary for exploring its relationship with HIV. Over the years it has also been difficult to distinguish severe bipolar illness from schizophrenia, and investigators looking at the relationship between HIV and mental illness have often simply employed the term \"chronically mentally ill\" for patients with severe disability from either schizophrenia or bipolar disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Clinical course of bipolar illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with bipolar illness classically present with extended episodes of low mood similar to major depression alternating with briefer manic episodes characterized by elevated mood, increased energy, increased confidence, sense of well-being and grandiose ideas about themselves and their circumstances. Elevated mood states form a continuum that ranges from hypomania (characterized by increased energy and elevated mood) to mania (characterized in its most severe state by hallucinations, delusions, disordered thinking and sometimes violently agitated behavior). These individuals report feeling elated and energized as if they are functioning better than normal. Their thoughts become more rapid and their horizons expand, such that they may feel that many brilliant ideas are presenting themselves in rapid succession.",
"   </p>",
"   <p>",
"    Hypomanic patients sometimes present with increased irritability that is paradoxical to their normal mood when they are well. There is often a noticeable increase in the amount and speed of speech and interrupting these patients can be difficult. With increased energy, these patients feel a decreased need for sleep and sometimes do not sleep at all. Elevated mood states transition into mania when symptoms impair judgment and function. In addition to pressured speech, manic patients often demonstrate flight of ideas, in which ideas come so quickly that it is impossible for the observer to make connections between them. Grandiose delusions, paranoid delusional thoughts, and hallucinations may also occur.",
"   </p>",
"   <p>",
"    Although patients most frequently cycle from one mood state to another with interspersed periods of normal mood, some patients may manifest features of both depressive and elevated mood states simultaneously (mixed state) or in very rapid successions (rapid cycling). The current literature describes bipolar illness type II, characterized by a milder form of mania.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     AIDS mania",
"    </span>",
"    &nbsp;&mdash;&nbsp;AIDS mania is uniquely associated with late-stage HIV infection. AIDS mania is characterized by typical mania and additional cognitive impairment in the setting of a lack of previous personal or family history of bipolar illness. AIDS mania has less euphoria and more irritability than idiopathic bipolar mania, and is also far more chronic. AIDS mania also does not appear to remit if left untreated. The prevalence of AIDS mania has greatly diminished now due to the advent of HAART.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manic syndromes in HIV patients occur with higher frequency after the onset of AIDS and at rates greater than observed in the general population. In one series, 8 percent of all AIDS patients seen at an HIV clinic over 17 months exhibited mania, which is more than 10 times the six-month general population prevalence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/26\">",
"     26",
"    </a>",
"    ]. This study grouped manic patients into those whose first manic episode came early with a CD4 count &gt;200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    and those whose first manic episode came late with a CD4 count",
"    <span class=\"nowrap\">",
"     &lt;200/microL.",
"    </span>",
"    Late-onset mania patients were less likely to have a personal history of mania or mood disorder, which presumably indicates that they were less likely to have bipolar disorder or a genetic predisposition to mania. These same individuals were also more likely to have dementia or other cognitive impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to mania in bipolar disorder, AIDS mania is associated with a worse prognosis, greater number of symptoms, more chronic course, and infrequent spontaneous remissions. AIDS mania patients are commonly irritable and infrequently hypertalkative or euphoric. Although it is difficult to ascertain the cognitive state in acute mania, the history is often different in patients with AIDS mania compared to those with bipolar mania. The former is frequently characterized by progressive cognitive decline prior to the onset of mania, typically accompanied by prominent psychomotor slowing. In contrast, a history of hyperactivity is common in bipolar mania [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A frequent manifestation of AIDS mania, either early or late, is the delusional belief that the patient has either been cured of HIV or has discovered the cure. This dangerous delusion often results in resumption of high-risk behavior and medication nonadherence. With cessation of treatment, AIDS mania usually relapses. Unfortunately these patients usually have cognitive deficits that render them less able to pursue treatment independently or consistently.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Bipolar illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of mania in early stage HIV is similar to standard treatment of mania in bipolar disorder: neuroleptics,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    salts or anticonvulsants such as valproic acid or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     AIDS mania",
"    </span>",
"    &nbsp;&mdash;&nbsp;AIDS mania patients frequently respond to treatment with neuroleptic agents alone. Because of their more favorable side effect profile relative to older \"typical neuroleptics\", newer \"atypical neuroleptics\", such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    (risperdal),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    (zyprexa),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    (seroquel) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    (geodon), are often considered first-line therapy. However, superior efficacy of atypical neuroleptics has not been demonstrated in clinical trials.",
"   </p>",
"   <p>",
"    Different treatment strategies are mandated as HIV disease progresses due to more accompanying medical illnesses, greater CNS involvement, and greater overall physiologic vulnerability. In late stage HIV disease the therapeutic dose of neuroleptics may be much lower due to greater sensitivity of these patients to both therapeutic and toxic neuroleptic effects.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    use in AIDS mania patients is often complicated by delirium, GI symptoms, or polyuria, which can lead to dehydration, sudden unpredictable changes in lithium levels, and diabetes insipidus.",
"   </p>",
"   <p>",
"    Valproic acid may be beneficial in AIDS mania patients when titrated to the usual therapeutic serum level of 50 to 100",
"    <span class=\"nowrap\">",
"     ng/dL.",
"    </span>",
"    AIDS patients usually tolerate enteric-coated tablets (Depakote) better due to a lower incidence of GI side effects. Treatment with valproic acid can be limited by possible hepatotoxicity, especially in patients with chronic viral hepatitis. The drug should probably be avoided in patients with substantial preexisting liver dysfunction due to infection (eg, hepatitis C or Mycobacterium avium complex [MAC] infection involving the liver) or cirrhosis (eg, portal hypertension).",
"   </p>",
"   <p>",
"    Because",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and valproic acid can diminish hematopoiesis, white blood cell and platelet counts should be monitored during treatment. Data are limited for the newer anticonvulsants, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    (neurontin) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    (lamictal) in the treatment of AIDS mania.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SCHIZOPHRENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence rates of severe and chronic mental illness in HIV-infected patients (historically encompassing schizophrenia and bipolar disorder) are estimated to range from four to 19 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/27\">",
"     27",
"    </a>",
"    ]. No evidence suggests that HIV causes schizophrenia, but data do support that schizophrenia contributes to high-risk behavior associated with HIV infection. Schizophrenic patients, for example, are more likely to engage in unprotected sex with multiple partners, trade sex for money or other goods, and have sex while intoxicated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/28\">",
"     28",
"    </a>",
"    ]. Despite demonstration of adequate knowledge of HIV risk factors, schizophrenic patients with more positive symptoms and impulse control problems are at increased risk for high-risk sexual behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12504/abstract/29\">",
"     29",
"    </a>",
"    ]. HIV-infected patients with schizophrenia are managed similarly to other patients with schizophrenia: control of symptoms with medications, psychosocial support and rehabilitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/12/35009?source=see_link\">",
"       \"Patient information: Dementia with HIV (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95740706\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychiatric disorders are common in patients infected with the human immunodeficiency virus (HIV), including major depression, mania, and schizophrenia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prevalence of major depression among HIV-infected patients ranges from 15 to 40 percent in different studies, and is twice as large in at-risk HIV-negative patients. The risk of major depression also appears to increase with progression of HIV infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among the symptoms of major depression (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"       table 3",
"      </a>",
"      ), the cardinal features in HIV-infected patients include decreased mood, vital sense, and self-worth; anhedonia; and neurovegetative features. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Response to antidepressant medication in HIV-infected patients with major depression is similar to that of other patients with major depression. No particular antidepressant is superior for HIV-infected patients. The most important component of antidepressant treatment is patient adherence, which is highly influenced by side effects experienced during treatment. Clinicians should also be aware of interactions between antidepressants and drugs used in highly active antiretroviral therapy (HAART) (",
"      <a class=\"graphic graphic_table graphicRef70410 \" href=\"UTD.htm?16/35/16945\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pharmacologic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of major depression with medication plus psychotherapy is likely to be more effective than either modality alone. The individual psychotherapies with the best evidence to support their use are interpersonal psychotherapy and cognitive-behavioral psychotherapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Psychotherapeutic'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"       \"Initial treatment of depression in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mania (",
"      <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"       table 4",
"      </a>",
"      ) occurs in HIV-infected patients either as a component of bipolar disorder, or as a unique entity known as AIDS mania caused by late-stage HIV infection. One study found that 8 percent of all AIDS patients seen over 17 months exhibited mania, more than 10 times the six-month general population prevalence. AIDS mania is characterized by typical mania and additional cognitive impairment in the setting of a lack of previous personal or family history of bipolar disorder. AIDS mania has less euphoria and more irritability than idiopathic bipolar mania, and is also more chronic. The prevalence of AIDS mania has greatly diminished now due to the advent of HAART. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Mania'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of mania in early stage HIV is similar to standard treatment of mania in bipolar disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link\">",
"       \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The prevalence of schizophrenia in HIV-infected patients is not known. No evidence suggests that HIV causes schizophrenia, but data indicate that schizophrenia contributes to high-risk behavior associated with HIV infection. Treatment of schizophrenia in HIV-infected patients is similar to standard treatment of schizophrenia. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Schizophrenia'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=see_link\">",
"       \"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/1\">",
"      Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 44:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/2\">",
"      Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004; 37:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/3\">",
"      van Servellen G, Chang B, Garcia L, Lombardi E. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDS 2002; 16:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/4\">",
"      Angelino AF, Treisman GJ. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis 2001; 33:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/5\">",
"      Compton WM, Cottler LB, Ben-Abdallah A, et al. The effects of psychiatric comorbidity on response to an HIV prevention intervention. Drug Alcohol Depend 2000; 58:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/6\">",
"      Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/7\">",
"      Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med 2003; 18:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/8\">",
"      Treisman G, Fishman M, Schwartz J, et al. Mood disorders in HIV infection. Depress Anxiety 1998; 7:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/9\">",
"      Atkinson JH Jr, Grant I, Kennedy CJ, et al. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry 1988; 45:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/10\">",
"      Perkins DO, Stern RA, Golden RN, et al. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994; 151:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/11\">",
"      Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/12\">",
"      Lyketsos CG, Hoover DR, Guccione M, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996; 153:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/13\">",
"      Haller DL, Miles DR. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of life. AIDS Behav 2003; 7:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/14\">",
"      Carrico AW, Johnson MO, Morin SF, et al. Correlates of suicidal ideation among HIV-positive persons. AIDS 2007; 21:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/15\">",
"      Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS 2005; 19:2057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/16\">",
"      Iovieno N, Tedeschini E, Ameral VE, et al. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. Int Clin Psychopharmacol 2011; 26:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/17\">",
"      Thompson A, Silverman B, Dzeng L, Treisman G. Psychotropic medications and HIV. Clin Infect Dis 2006; 42:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/18\">",
"      Yun LW, Maravi M, Kobayashi JS, et al. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/19\">",
"      Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007; 21:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/20\">",
"      Willig JH, Abroms S, Westfall AO, et al. Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS 2008; 22:1951.",
"     </a>",
"    </li>",
"    <li>",
"     Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 1&ndash;239. Available at file://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/22\">",
"      Bauer M, Hellweg R, Gr&auml;f KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998; 18:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/23\">",
"      Nelson JC. Augmentation strategies in depression 2000. J Clin Psychiatry 2000; 61 Suppl 2:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/24\">",
"      Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993; 50:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/25\">",
"      Nemeroff CB. Augmentation regimens for depression. J Clin Psychiatry 1991; 52 Suppl:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/26\">",
"      Lyketsos CG, Schwartz J, Fishman M, Treisman G. AIDS mania. J Neuropsychiatry Clin Neurosci 1997; 9:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/27\">",
"      Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002; 53:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/28\">",
"      Cournos F, Guido JR, Coomaraswamy S, et al. Sexual activity and risk of HIV infection among patients with schizophrenia. Am J Psychiatry 1994; 151:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12504/abstract/29\">",
"      McKinnon K, Cournos F, Sugden R, et al. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. J Clin Psychiatry 1996; 57:506.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4864 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C3286EAA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12504=[""].join("\n");
var outline_f12_13_12504=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H95740706\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MAJOR DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Etiologies of major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pharmacologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Dose and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Drug interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Augmentation strategy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Changing drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Psychotherapeutic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MANIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Clinical course of bipolar illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      AIDS mania",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Clinical course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Bipolar illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - AIDS mania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SCHIZOPHRENIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95740706\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/4864\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/4864|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/35/16945\" title=\"table 1\">",
"      Antidepressants in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/46/38639\" title=\"table 2\">",
"      Side effects antidepressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 3\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/53/3932\" title=\"table 4\">",
"      DSM-IV-TR diagnostic criteria for mania",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=related_link\">",
"      Dementia and delirium in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5831?source=related_link\">",
"      Overview of the neuropsychiatric aspects of HIV infection and AIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/12/35009?source=related_link\">",
"      Patient information: Dementia with HIV (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=related_link\">",
"      Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/50/22312?source=related_link\">",
"      Pituitary and adrenal gland dysfunction in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2039?source=related_link\">",
"      Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=related_link\">",
"      Substance abuse and addiction in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=related_link\">",
"      Treatment of resistant depression in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_13_12505="Clinical manifestations and diagnosis of acute renal allograft rejection";
var content_f12_13_12505=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of acute renal allograft rejection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12505/contributors\">",
"     W James Chon, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/13/12505/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/13/12505/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute renal allograft rejection is a major cause of allograft dysfunction. Some kidneys do not regain function even with maximal antirejection therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link\">",
"     \"Acute renal allograft rejection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even among patients who recover, acute rejection episodes have a negative impact on long-term graft survival. Acute rejection is the major predictor of chronic allograft nephropathy, which is responsible for most death-censored graft loss after the first year posttransplant. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=see_link&amp;anchor=H12#H12\">",
"     \"Chronic renal allograft nephropathy\", section on 'Importance of acute rejection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There has been a dramatic reduction in the incidence of acute rejection due to the introduction of potent immunosuppressive drugs in the past three decades. However optimizing immunosuppression to both prevent allograft rejection and minimize drug toxicity, infection, and malignancy remains challenging.",
"   </p>",
"   <p>",
"    A discussion of the clinical manifestations and diagnosis of acute renal allograft rejection is presented in this topic review. The treatment of acute rejection is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link\">",
"     \"Acute renal allograft rejection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H417236409\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute renal allograft rejection is defined as an acute deterioration in allograft function that is associated with specific pathologic changes in the graft. There are two principal histologic forms of acute rejection:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute cellular rejection, which is characterized by infiltration of the allograft by lymphocytes and other inflammatory cells.",
"     </li>",
"     <li>",
"      Acute antibody mediated rejection, the diagnosis of which requires morphologic evidence of acute tissue injury, circulating donor-specific allo-antibodies, and immunological evidence of an antibody-mediated process (such as C4d deposition in the allograft). Cellular infiltrates may not be present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It may be difficult to distinguish between acute antibody",
"    <strong>",
"    </strong>",
"    mediated rejection and severe acute cellular rejection, and the two processes may also coexist.",
"   </p>",
"   <p>",
"    Subclinical rejection is defined as the presence of histologic evidence of acute rejection on biopsy without an elevation in the serum creatinine concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. Subclinical rejection is primarily detected by a protocol, or surveillance, biopsy, which is obtained at a protocol-driven prespecified time after transplantation rather than for a clinical indication such as allograft dysfunction. Most of the reports of subclinical rejection involve cellular rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. However there are reports of allografts with histologic manifestations of antibody mediated rejection in the absence of functional deterioration of kidney function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H792382040\">",
"     'Subclinical rejection'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H417236440\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H792385721\">",
"    <span class=\"h2\">",
"     Acute rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advent of calcineurin inhibitors and anti-proliferative agents has dramatically lowered the incidence of acute rejection. The incidence of acute rejection reported to the United States Renal Data System in 2009 was approximately 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/10\">",
"     10",
"    </a>",
"    ]. By comparison, at least one acute rejection episode occurred in 50 to 60 percent of renal allograft recipients in the 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute rejection episodes are generally associated with a reduction in long-term allograft survival, although not all rejections episodes have the same impact on long-term graft function. Factors such as timing of rejection, severity and number of acute rejections, and degree of recovery of function after treatment all affect the long-term outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/12\">",
"     12",
"    </a>",
"    ]. If renal function returns to baseline, acute rejection does not necessarily cause irreparable damage or impact long-term graft survival [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite significant reductions in the incidence of acute rejection over the last decade, there has not been a similar improvement in long-term allograft survival. The underlying reasons for this are unclear. Possibilities include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is now a higher proportion of acute rejection episodes that fail to recover to previous baseline allograft function.",
"     </li>",
"     <li>",
"      Patients that are at high risk for cellular rejection are also at high risk for antibody mediated rejection. Although the use of potent induction agents may prevent acute cellular rejection in predisposed recipients, these patients may develop early chronic allograft nephropathy that is antibody-mediated and not easy to diagnose or treat.",
"     </li>",
"     <li>",
"      The beneficial effects of lower incidence of acute rejection are offset by the negative effects of over-immunosuppression [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H792382040\">",
"    <span class=\"h2\">",
"     Subclinical rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;As defined above, subclinical rejection is when histologic changes of acute rejection are observed in the absence of an increased serum creatinine concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. The incidence of subclinical rejection in the first six months after a renal transplantation is highly variable and depends on several factors including degree of HLA matching, immunosuppressive protocol, and the incidence of delayed graft function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As is acute rejection, subclinical rejection may be less common in the current era of immunosuppressive regimens. For example, in a multi-center randomized study of 240 renal transplant recipients treated with",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"      mycophenolate",
"     </a>",
"    </span>",
"    <span class=\"nowrap\">",
"     /glucocorticoids,",
"    </span>",
"    the overall prevalence of subclinical rejection was only 4.6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/16\">",
"     16",
"    </a>",
"    ], compared with a much higher prevalence cited in previous studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the studies on subclinical rejection involve cellular rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. However, one multicenter study examined the incidence of histologic manifestations of antibody mediated rejection in 551 protocol and 377 indication biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/9\">",
"     9",
"    </a>",
"    ]. The major histologic finding under study was C4d staining, which was generally associated with other morphologic evidence of antibody mediated rejection. Diffuse and focal C4d staining was observed in 2.0 and 2.4 percent of protocol biopsies, respectively, and in 12.2 and 8.5 percent of indication biopsies, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/9\">",
"     9",
"    </a>",
"    ]. The incidence of C4d-positive biopsies varied significantly between centers, with a higher percentage of C4d-positive biopsies noted at a center that transplanted a higher percentage of sensitized patients.",
"   </p>",
"   <p>",
"    Many [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1,2,4,18-23\">",
"     1,2,4,18-23",
"    </a>",
"    ] though not all [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/3,6\">",
"     3,6",
"    </a>",
"    ] studies have demonstrated an association between subclinical rejection demonstrated by protocol biopsy and decreased allograft survival",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    function. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 435 protocol biopsies, subclinical rejection with chronic allograft nephropathy was an independent predictor of allograft loss (relative risk 1.86, 95% CI 1.11-3.12) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Analysis of 833 protocol and 306 clinically-indicated biopsies found that the presence of persistent inflammation on sequential biopsies was a significant determinant of allograft function independent of an increased serum creatinine; the prevalence of inflammatory infiltrates was the same between protocol and clinically indicated biopsies [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The significance of subclinical C4d staining in relation to chronic antibody mediated rejection, chronic allograft nephropathy and long-term graft function is not clear. The 2005 Banff diagnostic criteria changed the antibody-mediated rejection category to reflect the finding of C4d in some cases of chronic allograft dysfunction, suggesting that antibody mediated rejection is a likely contributor to some forms of chronic nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=see_link&amp;anchor=H8#H8\">",
"     \"C4d staining in renal allografts and treatment of antibody mediated rejection\", section on 'chronic allograft nephropathy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=see_link&amp;anchor=H9#H9\">",
"     \"C4d staining in renal allografts and treatment of antibody mediated rejection\", section on 'Long term allograft function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unclear if the administration of therapy to patients with subclinical rejection improves clinical outcomes. This is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link&amp;anchor=H114799311#H114799311\">",
"     \"Acute renal allograft rejection: Treatment\", section on 'Subclinical and borderline rejection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H417236515\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most episodes of acute rejection occur within the first six months after transplantation, with many such episodes occurring early after surgery. Rejection after six months is typically from non-compliance or over aggressive reduction in immunosuppression.",
"   </p>",
"   <p>",
"    Most patients who have acute rejection episodes are asymptomatic. However, occasionally patients present with fever, malaise, oliguria, and graft pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/25\">",
"     25",
"    </a>",
"    ]. Hypertension is also a common finding [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/25\">",
"     25",
"    </a>",
"    ]. These manifestations are uncommon with modern immunosuppressive drug regimens, particularly calcineurin inhibitors, unless immunosuppression is completely discontinued. Since most patients are asymptomatic, acute rejection is suggested only by an increase in the serum creatinine. (See",
"    <a class=\"local\" href=\"#H124259700\">",
"     'Monitoring for acute rejection'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H417236522\">",
"    <span class=\"h2\">",
"     Laboratory manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute allograft rejection present with an acute rise in the serum creatinine. A rising serum creatinine level, however, is a relatively late development in the course of a rejection episode and usually indicates the presence of significant histological damage. Pyuria or new or worsening proteinuria may also be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H515116843\">",
"    <span class=\"h2\">",
"     Radiographic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most findings obtained by renal imaging are nonspecific and such studies are generally performed to exclude other causes of acute kidney injury. Ultrasonography typically shows increased graft size, with loss of corticomedullary junction, prominent hypoechoic pyramids and decreased echogenicity of the renal sinus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/25\">",
"     25",
"    </a>",
"    ]. Renal Doppler studies obtained via ultrasound may show elevated resistance indices (RIs) but this finding may also be observed with ureteral obstruction, acute tubular necrosis, renal vein occlusion, pyelonephritis, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Nuclear medicine renal scans may show delayed visualization of kidneys.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124259700\">",
"    <span class=\"h1\">",
"     MONITORING FOR ACUTE REJECTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124260006\">",
"    <span class=\"h2\">",
"     Laboratory monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, most patients who develop acute rejection are asymptomatic and present only with an increased serum creatinine. Often there is significant histologic damage that may be partially irreversible by the time the increase in creatinine is detected. As a result, routine monitoring of the serum creatinine is essential in order to detect a creatinine increase as early as possible. Most clinicians also follow blood pressure and urine protein excretion, although hypertension and proteinuria are less specific for rejection compared with the creatinine. Immediately after surgery, urine output is also followed as a parameter of kidney function.",
"   </p>",
"   <p>",
"    The frequency of monitoring depends upon the time from transplantation. Some centers, for example, routinely obtain serum creatinine levels and urine output every six hours for the first postoperative day, followed by one measurement every morning [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Upon discharge from the hospital, we monitor serum creatinine, urinalysis, urine protein to creatinine ratio and patient-reported vital signs according to the following schedule:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Twice weekly in the first month post-transplant.",
"     </li>",
"     <li>",
"      Weekly for months 1 to 4.",
"     </li>",
"     <li>",
"      Every other week for months 4 to 12.",
"     </li>",
"     <li>",
"      Monthly, after the first year indefinitely.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This strategy allows for assessment of compliance and early intervention upon detection of renal dysfunction. However, other clinics monitor stable patients less frequently after the first year (as an example, every two months for the second year and every three to four months, beginning in the third year) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients considered to be at increased risk of acute rejection (such as highly sensitized recipients who had a panel reactive antibody greater than 80 percent pre-transplant, retransplant recipients, African-Americans, 6-antigen mismatched patients, patients with donor specific antibodies, and non-compliant patients) should continue to have frequent laboratory monitoring for an extended period of time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/48/34570?source=see_link\">",
"     \"HLA and ABO sensitization and desensitization in renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another method of monitoring for acute rejection is to obtain protocol biopsies. The role, if any, for protocol biopsies is discussed below (see",
"    <a class=\"local\" href=\"#H124259722\">",
"     'Protocol (surveillance) biopsies'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124259722\">",
"    <span class=\"h2\">",
"     Protocol (surveillance) biopsies",
"    </span>",
"    &nbsp;&mdash;&nbsp;We generally do not perform protocol or surveillance biopsies unless required for a clinical trial. The term &ldquo;surveillance&rdquo; is preferred since it implies a clinical and reimbursable reason for the biopsy. Among patients with delayed graft function, we obtain surveillance biopsies weekly to every other week until graft function is established. Some centers obtain surveillance biopsies among renal transplant recipients at high risk for acute rejection, however we do not perform protocol or surveillance biopsies among these patients if renal function is adequate.",
"   </p>",
"   <p>",
"    The rationale for performing surveillance biopsies is that they are more sensitive than the serum creatinine for detecting acute rejection with up to 30 percent of protocol biopsies showing evidence of rejection among patients with stable renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/1-8\">",
"     1-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surveillance biopsies are, in general, safe and have a very low risk of graft loss (approximately 0.03 percent) and minimal risk of morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/5,8,29-31\">",
"     5,8,29-31",
"    </a>",
"    ]. The risk of major complications (including substantial bleeding, macroscopic hematuria with ureteric obstruction, peritonitis, or graft loss) is reportedly about 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/5,31\">",
"     5,31",
"    </a>",
"    ]. As acute rejection is often a patchy process, an adequate sampling of allograft tissue-at least 2 cores- that can be examined by an experienced renal pathologist is important in providing better diagnostic information [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although safe, surveillance biopsies are inconvenient and costly [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/29\">",
"     29",
"    </a>",
"    ]. The utility of surveillance biopsies is not clear since there is no conclusive evidence that the treatment of subclinical rejection improves long term outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124260168\">",
"    <span class=\"h2\">",
"     Selection of patients for biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rejection should be suspected among all transplant recipients who present with a creatinine that is increased above the patient&rsquo;s usual baseline, especially if they have associated symptoms such as fever, oliguria and graft pain or tenderness.",
"   </p>",
"   <p>",
"    Renal allograft biopsy with conventional histologic examination is the gold standard for diagnosing acute rejection among transplant patients with a deterioration in kidney function. However, among transplant recipients, there are other potential causes of an increased serum creatinine that do not require a biopsy to diagnose and should be excluded prior to performing a biopsy. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    We generally perform the following evaluation prior to performing a biopsy among transplant recipients who present with an increased serum creatinine:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measure the plasma calcineurin inhibitor concentration to exclude acute calcineurin inhibitor toxicity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link&amp;anchor=H2#H2\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\", section on 'Acute calcineurin inhibitor nephrotoxicity'",
"      </a>",
"      .).",
"      <br/>",
"      <br/>",
"      If the drug level is significantly elevated and the likely etiology of graft dysfunction, we reduce the dose. A renal biopsy is performed if no improvement is noted within one to two days after decreasing the dose.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obtain a renal ultrasound in order to exclude a urinary leak or obstruction.",
"      <br/>",
"      <br/>",
"      If the ultrasound is negative for obstruction or other causality, a biopsy is done. The indications for biopsy among kidney transplant recipients are discussed in depth elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link\">",
"       \"Acute renal allograft rejection: Treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2072?source=see_link&amp;anchor=H19#H19\">",
"       \"Differential diagnosis of renal allograft dysfunction\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2072?source=see_link&amp;anchor=H24#H24\">",
"       \"Differential diagnosis of renal allograft dysfunction\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many clinicians also measure blood CMV and BK viral loads among all patients who have an acute increase in the serum creatinine, since viral infection can mimic rejection and since the treatments of acute rejection and viral infection are diametrically opposed. Others measure blood BK viral loads only among patients who have high grade viruria detected on routine monitoring, and CMV viral loads only among patients with other clinical evidence of CMV infection (such as fever, leukopenia or other organ involvement). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link&amp;anchor=H222485#H222485\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\", section on 'Laboratory and radiographic findings'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=see_link&amp;anchor=H29#H29\">",
"     \"Cytomegalovirus infection in renal transplant recipients\", section on 'CMV disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, among all patients selected for BK and CMV viral load testing, the biopsy should not be delayed while awaiting the results of the viral tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124260175\">",
"    <span class=\"h2\">",
"     Histopathologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with rejection, the biopsy may show either cellular rejection or antibody-mediated rejection or both. The histologic criteria for both cellular and antibody-mediated rejection are presented in table 1 (",
"    <a class=\"graphic graphic_table graphicRef52378 \" href=\"UTD.htm?2/11/2237\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pathologic changes that occur with acute cellular rejection include interstitial infiltration with mononuclear cells and occasionally eosinophils, and disruption of the tubular basement membranes by the infiltrating cells (ie, tubulitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/33\">",
"     33",
"    </a>",
"    ]. Tubulitis and intimal arteritis are the primary lesions. The presence of patchy mononuclear cell infiltrates without tubulitis is not uncommon in normal functioning renal allografts and is not by itself sufficient to make the diagnosis of acute cellular rejection. The presence of neutrophils is uncommon and suggests the diagnosis of infection or antibody mediated rejection.",
"   </p>",
"   <p>",
"    Acute antibody-mediated rejection is characterized by capillary endothelial swelling, arteriolar fibrinoid necrosis, fibrin thrombi in glomerular capillaries, and frank cortical necrosis in severe cases. In general, severe vasculitis, glomerulitis with neutrophils in the glomerular capillaries and peritubular capillaries, fibrin thrombi, fibrinoid necrosis, and interstitial hemorrhage are more commonly seen with humoral or antibody mediated rejection compared with cellular rejection. The presence of C4d and donor specific antibodies is highly suggestive of antibody mediated rejection. The criteria required for a diagnosis of antibody-mediated rejection are shown in table 2 (",
"    <a class=\"graphic graphic_table graphicRef82577 \" href=\"UTD.htm?2/23/2428\">",
"     table 2",
"    </a>",
"    ). However, antibody-mediated rejection&nbsp;may also present only with evidence of acute tubular necrosis (ATN) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/34\">",
"     34",
"    </a>",
"    ]. A detailed discussion of this issue is available in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=see_link\">",
"     \"C4d staining in renal allografts and treatment of antibody mediated rejection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plasma cells, which normally account for less than 10 percent of interstitial mononuclear cells in the setting of acute rejection, may occasionally be the predominant cell type in acute antibody mediated rejection. The plasma cell infiltrate may represent a form of antibody-mediated rejection, since it can be associated with C4d staining as well as donor-specific and anti-endothelial antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. Alternatively, the plasma cell infiltrate may result from a preceding viral infection with CMV or EBV, which can lead to antibody-mediated rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It may be difficult to distinguish between acute antibody",
"    <strong>",
"    </strong>",
"    mediated rejection and severe acute cellular rejection, and the two processes may also coexist. In addition, in up to 25 percent of cases of allograft dysfunction attributed at least in part to antibody-mediated rejection, the histologic findings are suggestive of only cellular rejection or acute tubular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/34\">",
"     34",
"    </a>",
"    ]. It is important to identify antibody-mediated rejection if possible, since it is often refractory to treatment modalities aimed at acute cellular rejection and, unless adequately treated, often results in renal allograft loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link&amp;anchor=H23#H23\">",
"     \"Acute renal allograft rejection: Treatment\", section on 'Antibody mediated rejection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There have been various attempts to standardize the histologic criteria for acute rejection in order to allow comparisons of efficacy of different therapies and to help guide treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/40\">",
"     40",
"    </a>",
"    ]. Classification systems that have been introduced include the Banff classification system published in 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/33\">",
"     33",
"    </a>",
"    ], and the Cooperative Clinical Trials in Transplantation (CCTT) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/41\">",
"     41",
"    </a>",
"    ]. Both classifications systems focused upon inflammation involving arteries and tubules, and did not incorporate evidence of glomerulitis, since the significance of glomerulitis is unclear.",
"   </p>",
"   <p>",
"    The Banff and the CCTT systems were both incorporated into the Banff 97 classification [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/42\">",
"     42",
"    </a>",
"    ]. (",
"    <a class=\"graphic graphic_table graphicRef52378 \" href=\"UTD.htm?2/11/2237\">",
"     table 1",
"    </a>",
"    ) Increased histologic severity based upon the 1997 Banff classification correlated with unresponsiveness to therapy and decreased allograft survival [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Banff 97 diagnostic categories have since been modestly revised [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/24,44-46\">",
"     24,44-46",
"    </a>",
"    ]. The Banff 2011 Conference on Allograft Pathology recognized the existence of C4d-negative antibody-mediated rejection in renal allografts but stopped short of adding a diagnostic category of C4d-negative antibody-mediated rejection. C4d-negative antibody-mediated rejection is often seen in patients with donor specific antibodies and persistent microcirculation inflammation (i.e. capillaritis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    glomerulitis) resulting in chronic microvascular remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/46\">",
"     46",
"    </a>",
"    ]. The timing, type of transplant, and technique used to detect C4d may impact the detection of and interpretation of C4d or its absence. A detailed discussion of antibody-mediated rejection is available in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=see_link\">",
"     \"C4d staining in renal allografts and treatment of antibody mediated rejection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other methods used to help diagnosis acute kidney rejection have been the focus of a large number of investigators and are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/20/19780?source=see_link\">",
"     \"Investigational methods in the diagnosis of acute renal allograft rejection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other diseases, including post-transplantation lymphoproliferative disease (PTLD), CMV disease, polyoma (BK) viral disease, interstitial nephritis and pyelonephritis may have similar histologic findings to allograft rejection.",
"   </p>",
"   <p>",
"    Among all patients who have histologic findings consistent with PTLD, we perform special stains for T and B cell populations, EBV antigens, and monoclonal light chains in the kidney. We also perform quantitative blood assays for EBV by PCR, and serum and urine protein electrophoresis. Among patients in whom PTLD is being considered, we image the graft, the abdomen, and pelvis by CT scans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23338?source=see_link\">",
"     \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CMV and BK virus may be excluded by measuring viral loads in blood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44230?source=see_link\">",
"     \"Viral load testing for cytomegalovirus in solid organ transplant recipients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\", section on 'Diagnosis'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p>",
"    Special stains for BK should also be performed on the biopsy sample. It is essential that medullary tissue be available for analysis since BK is tropic for medullary tubules more than cortical tubules. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H515115855\">",
"    <span class=\"h2\">",
"     Clinical symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who have acute rejection episodes are asymptomatic. However, occasionally patients present with fever, malaise, oliguria, and graft pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/25\">",
"     25",
"    </a>",
"    ]. Hypertension is also a common finding [",
"    <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/25\">",
"     25",
"    </a>",
"    ]. Among patients who present with fever, malaise, oliguria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    graft pain or tenderness, the diagnosis of infection, urinary leak, and obstruction should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40084?source=see_link\">",
"     \"Differential diagnosis of infection following renal transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=see_link\">",
"     \"Diagnosis of urinary tract obstruction and hydronephrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Elevated serum creatinine",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described above, most patients with acute rejection are asymptomatic and present only with an elevated creatinine. The causes of renal allograft dysfunction as detected by an elevated serum creatinine concentration vary with the time after transplantation and are generally classified as immediate, early, and late period dysfunction. Causes include prerenal (hypotension, volume depletion, and if immediately post-operative, renal artery thrombosis), postrenal (bladder dysfunction or ureteral obstruction) and intrinsic renal (including acute tubular necrosis, calcineurin inhibitor or other drug toxicity, viral infection, or recurrent disease). In general these are distinguished from rejection by the evaluation described above. (See",
"    <a class=\"local\" href=\"#H124260168\">",
"     'Selection of patients for biopsy'",
"    </a>",
"    above.) The differential diagnosis of allograft dysfunction is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2072?source=see_link\">",
"     \"Differential diagnosis of renal allograft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Histologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-transplantation lymphoproliferative disease (PTLD), CMV disease, polyoma (BK) viral disease, interstitial nephritis and pyelonephritis may have similar histologic findings to allograft rejection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Post-transplantation lymphoproliferative disease (PTLD)  PTLD is suggested by a diffuse lymphocytic infiltrate of such severity that it is difficult to visualize tubular architecture, which can occasionally be observed in patients with severe cellular rejection (frequently secondary to noncompliance with immunosuppression).",
"      <br/>",
"      <br/>",
"      Since the treatment options for rejection and PTLD are markedly different, additional studies must be performed to differentiate the two possibilities. Studies include special stains for T and B cell populations, EBV antigens, and monoclonal light chains, as well as quantitative EBV polymerase chain reaction (PCR) and serum and urine protein electrophoresis. Imaging of the graft should also include the abdomen, pelvis, and any other clinically relevant areas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23338?source=see_link\">",
"       \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"      </a>",
"      .) Detection of specific cell markers for T-cells, B-cells, plasma cells, and monocytes may also be useful to guide rejection therapy in the setting of a significant cellular infiltrate with graft dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytomegalovirus infection (CMV)  CMV may manifest as an increased serum creatinine with a renal biopsy histologic appearance similar to rejection. In one study, treatment of the CMV rather than anti-rejection treatment with increased immunosuppression was associated with &ldquo;reversal&rdquo; of rejection and improvement in graft function in 17 of 21 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/47\">",
"       47",
"      </a>",
"      ]. In general, whole blood or plasma CMV viral load testing will identify patients with active CMV disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      BK nephropathy  The histologic appearance of BK nephropathy may mimic the tubulitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      arteritis classically associated with rejection [",
"      <a class=\"abstract\" href=\"UTD.htm?12/13/12505/abstract/48\">",
"       48",
"      </a>",
"      ]. Among such patients, it is extremely important to attempt to differentiate BK nephropathy from rejection, as the two treatments are diametrically opposed, and increased immunosuppression in the setting of BK nephropathy will lead to further viral proliferation and potential allograft loss.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <br/>",
"    As noted above, some clinicians routinely check blood BK PCR in the setting of allograft dysfunction or in the setting of histologic findings suggestive of rejection. Others only check blood BK PCR among patients who have high grade viruria detected on routine monitoring. (See",
"    <a class=\"local\" href=\"#H124260168\">",
"     'Selection of patients for biopsy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link&amp;anchor=H222485#H222485\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\", section on 'Laboratory and radiographic findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among all patients, special stains for BK should be performed on the biopsy sample if there is concern for BK nephropathy, even in the absence of typical viral inclusions on the biopsy. It is essential that medullary tissue be available for analysis since BK is tropic for medullary tubules more than cortical tubules (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    ). The rate of progression of allograft dysfunction can also sometimes help in differentiating rejection from viral infection. BK nephropathy alone rarely causes an acute increase in the serum creatinine concentration in the absence of concurrent rejection or another process. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42712?source=see_link\">",
"     \"Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drug- or infection-related interstitial nephritis  Drug or infection-related interstitial nephritis may also mimic rejection. Urine eosinophilia may suggest drug induced acute interstitial nephritis, although its absence does not exclude its presence.",
"     </li>",
"     <li>",
"      Transplant pyelonephritis  Transplant pyelonephritis can cause an elevation in serum creatinine as well as interstitial and tubular infiltrates. However, the infiltrate mostly consists of polymorphonuclear cells rather than lymphocytes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute renal allograft rejection is a major cause of allograft dysfunction, though it is much less common since the advent of more potent immunosuppressive agents, particularly including calcineurin inhibitors. Some kidneys that develop acute rejection do not regain function even with maximal antirejection therapy. Acute rejection episodes have a negative impact on long-term graft survival. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two principal forms of acute rejection include cellular and antibody mediated.",
"      <br/>",
"      <br/>",
"      Subclinical rejection is present when there are histologic manifestations without a functional decline in kidney function. (See",
"      <a class=\"local\" href=\"#H417236409\">",
"       'Definitions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H417236440\">",
"       'Epidemiology and outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute rejection usually occurs within the first six months after transplantation. After six months, rejection is usually from non-compliance or over aggressive reduction in immunosuppression. Although the classic signs and symptoms include fever, malaise, oliguria, graft pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tenderness, graft swelling and hypertension, these manifestations are uncommon with modern immunosuppressive drug regimens, and most patients just present with an increase in the serum creatinine. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We monitor for rejection by determining serum creatinine, urinalysis, urine protein to creatinine ratio and patient-reported vital signs according to the following schedule:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Twice weekly in the first month post-transplant.",
"     </li>",
"     <li>",
"      Weekly for months 1 to 4.",
"     </li>",
"     <li>",
"      Every other week for months 4 to 12.",
"     </li>",
"     <li>",
"      Monthly, after the first year indefinitely.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We do not perform surveillance biopsies. (See",
"    <a class=\"local\" href=\"#H124259722\">",
"     'Protocol (surveillance) biopsies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis is made by renal biopsy. Prior to performing a biopsy, other common causes of acute kidney injury should be excluded prior to biopsy. We measure the plasma calcineurin inhibitor concentration and obtain an ultrasound prior to biopsy. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients who present with fever, malaise, oliguria, and graft pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tenderness and hypertension the major differential diagnoses are viral infection, (BK, cytomegalovirus [CMV], and adenovirus) or bacterial pyelonephritis, urinary leak, and obstruction. Most patients however are asymptomatic and present only with an increased serum creatinine. Among such patients, the differential diagnosis depends with the time after transplantation and includes pre-, post- and intrinsic renal causes. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2072?source=see_link\">",
"       \"Differential diagnosis of renal allograft dysfunction\"",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      The histology observed in acute rejection may also be seen in other conditions including post-transplantation lymphoproliferative disease (PTLD), CMV and polyoma (BK) virus, interstitial nephritis and transplant pyelonephritis. Additional studies may be required to differentiate these possibilities. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Histologic findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/1\">",
"      Rush DN, Henry SF, Jeffery JR, et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/2\">",
"      Shapiro R, Jordan ML, Scantlebury VP, et al. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist? Transplantation 2000; 69:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/3\">",
"      Roberts IS, Reddy S, Russell C, et al. Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation. Transplantation 2004; 77:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/4\">",
"      Kee TY, Chapman JR, O'Connell PJ, et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/5\">",
"      Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6:2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/6\">",
"      Scholten EM, Rowshani AT, Cremers S, et al. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 2006; 17:2622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/7\">",
"      Ser&oacute;n D, Moreso F. Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int 2007; 72:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/8\">",
"      Thaunat O, Legendre C, Morelon E, et al. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation 2007; 84:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/9\">",
"      Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5:1050.",
"     </a>",
"    </li>",
"    <li>",
"     www.USRDS.org (Accessed on May 16, 2009).",
"    </li>",
"    <li>",
"     Cecka, JM, Terasaki, PI. Early rejection episodes. In: Clinical Transplants, Terasaki, PI (Eds), UCLA Tissue Typing Laboratory, Los Angeles 1989. p.425.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/12\">",
"      Opelz G, D&ouml;hler B, Collaborative Transplant Study Report. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 2008; 85:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/13\">",
"      Madden RL, Mulhern JG, Benedetto BJ, et al. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int 2000; 13:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/14\">",
"      Vereerstraeten P, Abramowicz D, de Pauw L, Kinnaert P. Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery. Transplantation 1997; 63:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/15\">",
"      Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/16\">",
"      Rush D, Arlen D, Boucher A, et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 2007; 7:2538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/17\">",
"      Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/18\">",
"      Nankivell BJ, Borrows RJ, Fung CL, et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/19\">",
"      Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/20\">",
"      Moreso F, Ibernon M, Gom&agrave; M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/21\">",
"      Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5:2464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/22\">",
"      Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/23\">",
"      Choi BS, Shin MJ, Shin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005; 5:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/24\">",
"      Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7:518.",
"     </a>",
"    </li>",
"    <li>",
"     Pham, PTT, Nast, et al. Diagnosis and therapy of graft dysfunction. In: Chronic kidney disease, dialysis and transplantation, 2, Periera, BJG, Sayegh, et al.  (Eds), Elsevier Saunders, Philadelphia 2005. p.641.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/26\">",
"      Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004; 15:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/27\">",
"      Desvaux D, Schwarzinger M, Pastural M, et al. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 2004; 78:647.",
"     </a>",
"    </li>",
"    <li>",
"     Amend, WJ, Vincenti, et al. The first three postansplant months. In: Handbook of Kidney Transplantation, 4th ed, Danovitch GM (Ed), Lippincott Williams &amp; Wilkins, Philadelphia, PA 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/29\">",
"      Furness PN, Philpott CM, Chorbadjian MT, et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 2003; 76:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/30\">",
"      Fereira LC, Karras A, Martinez F, et al. Complications of protocol renal biopsy. Transplantation 2004; 77:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/31\">",
"      Schwarz A, Gwinner W, Hiss M, et al. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 2005; 5:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/32\">",
"      Sorof JM, Vartanian RK, Olson JL, et al. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 1995; 60:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/33\">",
"      Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/34\">",
"      Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/35\">",
"      Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004; 19:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/36\">",
"      Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/37\">",
"      Aiello FB, Calabrese F, Rigotti P, et al. Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol 2004; 17:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/38\">",
"      Poduval RD, Kadambi PV, Josephson MA, et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005; 79:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/39\">",
"      Moll S, Pascual M. Humoral rejection of organ allografts. Am J Transplant 2005; 5:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/40\">",
"      Furness PN, Taub N, Convergence of European Renal Transplant Pathology Assessment Procedures (CERTPAP) Project. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int 2001; 60:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/41\">",
"      Colvin RB, Cohen AH, Saiontz C, et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/42\">",
"      Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/43\">",
"      Mueller A, Schnuelle P, Waldherr R, van der Woude FJ. Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation. Transplantation 2000; 69:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/44\">",
"      Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/45\">",
"      Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/46\">",
"      Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/47\">",
"      Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/13/12505/abstract/48\">",
"      McGilvray ID, Lajoie G, Humar A, Cattral MS. Polyomavirus infection and acute vascular rejection in a kidney allograft: coincidence or mimicry? Am J Transplant 2003; 3:501.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7352 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-2A8E9B1E90-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12505=[""].join("\n");
var outline_f12_13_12505=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H417236409\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H417236440\">",
"      EPIDEMIOLOGY AND OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H792385721\">",
"      Acute rejection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H792382040\">",
"      Subclinical rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H417236515\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H417236522\">",
"      Laboratory manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H515116843\">",
"      Radiographic manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H124259700\">",
"      MONITORING FOR ACUTE REJECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124260006\">",
"      Laboratory monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124259722\">",
"      Protocol (surveillance) biopsies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124260168\">",
"      Selection of patients for biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124260175\">",
"      Histopathologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H515115855\">",
"      Clinical symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Elevated serum creatinine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Histologic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7352\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7352|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2237\" title=\"table 1\">",
"      Banff diagnostic criteria reject allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/23/2428\" title=\"table 2\">",
"      Diagnostic criteria for AMR reject of renal allograft",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=related_link\">",
"      Acute renal allograft rejection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=related_link\">",
"      C4d staining in renal allografts and treatment of antibody mediated rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=related_link\">",
"      Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=related_link\">",
"      Cytomegalovirus infection in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=related_link\">",
"      Diagnosis of urinary tract obstruction and hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40084?source=related_link\">",
"      Differential diagnosis of infection following renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2072?source=related_link\">",
"      Differential diagnosis of renal allograft dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/48/34570?source=related_link\">",
"      HLA and ABO sensitization and desensitization in renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/20/19780?source=related_link\">",
"      Investigational methods in the diagnosis of acute renal allograft rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42712?source=related_link\">",
"      Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23338?source=related_link\">",
"      Treatment and prevention of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44230?source=related_link\">",
"      Viral load testing for cytomegalovirus in solid organ transplant recipients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_13_12506="CDC Medical Eligibility Criteria for Contraceptive Use";
var content_f12_13_12506=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    US Medical Eligibility Criteria for Contraceptive Use: Summary of classifications for hormonal contraceptive methods and intrauterine devices",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"40%\">",
"     </colgroup>",
"     <colgroup span=\"12\" width=\"5%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"13\">",
"        Health-care providers can use the summary table as a quick reference guide to the classifications for hormonal contraceptive methods and intrauterine contraception and to compare classifications across these methods. See the full appendix for each method for clarifications to the numeric categories, as well as for summaries of the evidence and additional comments.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\" colspan=\"13\">",
"        BOX. Categories for classifying hormonal contraceptives and IUDs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <p>",
"         1 = A condition for which there is no restriction for the use of the contraceptive method.",
"        </p>",
"        <p>",
"         2 = A condition for which the advantages of using the method generally outweigh the theoretical or proven risks.",
"        </p>",
"        <p>",
"         3 = A condition for which the theoretical or proven risks usually outweigh the advantages of using the method.",
"        </p>",
"        <p>",
"         4 = A condition that represents an unacceptable health risk if the contraceptive method is used.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        COC/P/R",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        POP",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        DMPA",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Implants",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        LNG-IUD",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Cu-IUD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Personal characteristics and reproductive history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Pregnancy",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Not applicable*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Not applicable*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Not applicable*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Not applicable*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        <strong>",
"         Age",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;40 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;18 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;18 yrs = 2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;18 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;20 yrs = 2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        Menarche to",
"        <br/>",
"        &lt;20 yrs = 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        &ge;40 yrs = 2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        18-45 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        18-45 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        18-45 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &ge;20 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &ge;20 yrs = 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &gt;45 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &gt;45 yrs = 2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &gt;45 yrs = 1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Parity",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Nulliparous",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Parous",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Postpartum",
"        </strong>",
"        (nonbreastfeeding women)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. &lt;21 days",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. 21 days to 42 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. With other risk factors for VTE (such as age &ge;35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, BMI &ge;30, postpartum hemorrhage, postcesarean delivery, preeclampsia or smoking)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Without other risk factors for VTE",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. &gt;42 days",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Postpartum",
"        </strong>",
"        (breastfeeding women",
"        <sup>",
"         &loz;",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. &lt;21 days",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. 21 to &lt;30 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. With other risk factors for VTE (such as age &ge;35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, BMI &ge;30 kg/m",
"        <sup>",
"         2",
"        </sup>",
"        , postpartum hemorrhage, postcesarean delivery, preeclampsia or smoking)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Without other risk factors for VTE",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        c. 30 to 42 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. With other risk factors for VTE (such as age &ge;35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, BMI &ge;30, postpartum hemorrhage, postcesarean delivery, preeclampsia or smoking)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Without other risk factors for VTE",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. &gt;42 days",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Postpartum",
"        </strong>",
"        (breastfeeding or nonbreastfeeding women, including post-Cesarean section)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. &lt;10 min after delivery of the placenta",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. 10 min after delivery of the placenta to &lt;4 wks",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. &ge;4 wks",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. Puerperal sepsis",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Postabortion",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. First trimester",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Second trimester",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Immediate postseptic abortion",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Past ectopic pregnancy",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         History of pelvic surgery",
"        </strong>",
"        (see postpartum, including Cesarean section)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Smoking",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Age &lt;35 yrs",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. Age &ge;35 yrs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. &lt;15 Cigarettes/day",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. &ge;15 Cigarettes/day",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Obesity",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. &ge;30 kg/m",
"        <sup>",
"         2",
"        </sup>",
"        BMI",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Menarche to &lt;18 yrs and &ge;30 kg/m",
"        <sup>",
"         2",
"        </sup>",
"        BMI",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         History of bariatric surgery",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Restrictive procedures: decrease storage capacity of the stomach (vertical banded gastroplasty, laparoscopic adjustable gastric band, laparoscopic sleeve gastrectomy)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        b. Malabsorptive procedures: decrease absorption of nutrients and calories by shortening the functional length of the small intestine (Roux-en-Y gastric bypass, biliopancreatic diversion)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        <p>",
"         COCs: 3",
"        </p>",
"        <p>",
"         P/R: 1",
"        </p>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Multiple risk factors for arterial cardiovascular disease",
"        </strong>",
"        (such as older age, smoking, diabetes, and hypertension)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3/4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Hypertension",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Adequately controlled hypertension",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. Elevated blood pressure levels (properly taken measurements)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. Systolic 140 to 159 mmHg or diastolic 90 to 99 mmHg",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Systolic &ge;160 mmHg or diastolic &ge;100 mmHg",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Vascular disease",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         History of high blood pressure during pregnancy",
"        </strong>",
"        (where current blood pressure is measurable and normal)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Deep venous thrombosis (DVT)/pulmonary embolism (PE)",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        a. History of DVT/PE, not on anticoagulant therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        <p>",
"         i. Higher risk for recurrent DVT/PE (&ge;1 risk factors)",
"        </p>",
"        <ul>",
"         <li>",
"          History of estrogen-associated DVT/PE",
"         </li>",
"         <li>",
"          Pregnancy-associated DVT/PE",
"         </li>",
"         <li>",
"          Idiopathic DVT/PE",
"         </li>",
"         <li>",
"          Known thrombophilia, including antiphospholipid syndrome",
"         </li>",
"         <li>",
"          Active cancer (metastatic, on therapy, or within 6 mos after clinical remission), excluding non-melanoma skin cancer",
"         </li>",
"         <li>",
"          History of recurrent DVT/PE",
"         </li>",
"        </ul>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Lower risk for recurrent DVT/PE (no risk factors)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Acute DVT/PE",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        c. DVT/PE and established on anticoagulant therapy for at least 3 mos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        <p>",
"         i. Higher risk for recurrent DVT/PE (&ge;1 risk factors)",
"        </p>",
"        <ul>",
"         <li>",
"          Known thrombophilia, including antiphospholipid syndrome",
"         </li>",
"         <li>",
"          Active cancer (metastatic, on therapy, or within 6 mos after clinical remission), excluding non-melanoma skin cancer",
"         </li>",
"         <li>",
"          History of recurrent DVT/PE",
"         </li>",
"        </ul>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Lower risk for recurrent DVT/PE (no risk factors)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. Family history (first-degree relatives)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        e. Major surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. With prolonged immobilization",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Without prolonged immobilization",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        f. Minor surgery without immobilization",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Known thrombogenic mutations",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"        (eg, factor V Leiden; prothrombin mutation; protein S, protein C, and antithrombin deficiencies)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Superficial venous thrombosis",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Varicose veins",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Superficial thrombophlebitis",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        <strong>",
"         Current and history of ischemic heart disease",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        <strong>",
"         Stroke",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"        (history of cerebrovascular accident)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Known hyperlipidemias",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Valvular heart disease",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Uncomplicated",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Complicated",
"        <sup>",
"         &sect;",
"        </sup>",
"        (pulmonary hypertension, risk for atrial fibrillation, history of subacute bacterial endocarditis)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Peripartum cardiomyopathy",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        a. Normal or mildly impaired cardiac function (New York Heart Association Functional Class I or II: patients with no limitation of activities or patients with slight, mild limitation of activity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. &lt;6 mos",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. &ge;6 mos",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        b. Moderately or severely impaired cardiac function (New York Heart Association Functional Class III or IV: patients with marked limitation of activity or patients who should be at complete rest)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Rheumatic diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Systemic lupus erythematosus",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Positive (or unknown) antiphospholipid antibodies",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Severe thrombocytopenia",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Immunosuppressive treatment",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. None of the above",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Rheumatoid arthritis",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. On immunosuppressive therapy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        b. Not on immunosuppressive therapy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Neurologic conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Headaches",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Non-migrainous (mild or severe)",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. Migraine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\" colspan=\"13\">",
"        i. Without aura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - Age &lt;35 yrs",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        3*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - Age &ge;35 yrs",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        3*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        4*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2*",
"       </td>",
"       <td class=\"sublist_other_centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. With aura (at any age)",
"       </td>",
"       <td class=\"centered\">",
"        4*",
"       </td>",
"       <td class=\"centered\">",
"        4*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Epilepsy",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\" colspan=\"13\">",
"        If on treatment, see Drug interactions section below",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Depressive disorders",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        <strong>",
"         Depressive disorders",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Reproductive tract infections and disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Vaginal bleeding patterns",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Irregular pattern without heavy bleeding",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Heavy or prolonged bleeding (includes regular and irregular patterns)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Unexplained vaginal bleeding",
"        </strong>",
"        (suspicious for serious condition)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Before evaluation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        4*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        4*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Endometriosis",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Benign ovarian tumors",
"        </strong>",
"        (including cysts)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Severe dysmenorrhea",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Gestational trophoblastic disease",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Decreasing or undetectable &beta;-hCG levels",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Persistently elevated &beta;-hCG levels or malignant disease",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Cervical ectropion",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Cervical intraepithelial neoplasia",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        <strong>",
"         Cervical cancer",
"        </strong>",
"        (awaiting treatment)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Breast disease",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Undiagnosed mass",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Benign breast disease",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Family history of cancer",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        d. Breast cancer",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. Current",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Past and no evidence of current disease for 5 yrs",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Endometrial hyperplasia",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        <strong>",
"         Endometrial cancer",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Ovarian cancer",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Uterine fibroids",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Anatomical abnormalities",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Distorted uterine cavity (any congenital or acquired uterine abnormality distorting the uterine cavity in a manner that is incompatible with IUD insertion)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Other abnormalities (including cervical stenosis or cervical lacerations) not distorting the uterine cavity or interfering with IUD insertion",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Pelvic inflammatory disease (PID)",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Past PID (assuming no current risk factors of STIs)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. With subsequent pregnancy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Without subsequent pregnancy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Current PID",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         STIs",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Current purulent cervicitis or chlamydial infection or gonorrhea",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Other STIs (excluding HIV and hepatitis)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Vaginitis (including",
"        <em>",
"         Trichomonas vaginalis",
"        </em>",
"        and bacterial vaginosis)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. Increased risk for STIs",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         HIV/AIDS",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         High risk for HIV",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         HIV infection",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         AIDS",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        &nbsp;",
"       </td>",
"       <td colspan=\"8\">",
"        NOTE: If on treatment, drug interactions might exist between hormonal contraceptives, including LNG-IUD, and antiretroviral drugs; refer to the section on drug interactions below as there may be limitations to use of the method.",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Other infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Schistosomiasis",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Uncomplicated",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Fibrosis of the liver (if severe, see Cirrhosis)",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Tuberculosis",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Nonpelvic",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Pelvic",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        If on treatment, see Drug interactions section below",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        <strong>",
"         Malaria",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Endocrine conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Diabetes",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. History of gestational disease",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        b. Nonvascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. Noninsulin-dependent",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Insulin-dependent",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Nephropathy/retinopathy/ neuropathy",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3/4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. Other vascular disease or diabetes of &gt;20 yrs' duration",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3/4*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Thyroid disorders",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Simple goiter",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Hyperthyroid",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        c. Hypothyroid",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Gastrointestinal conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Inflammatory bowel disease (IBD)",
"        </strong>",
"        (ulcerative colitis, Crohn disease)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Gallbladder disease",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        a. Symptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. Treated by cholecystectomy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Medically treated",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        iii. Current",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Asymptomatic",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         History of cholestasis",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Pregnancy-related",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Past COC-related",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Viral hepatitis",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Acute or flare",
"       </td>",
"       <td class=\"centered\">",
"        3/4*",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Carrier",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Chronic",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Cirrhosis",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Mild (compensated)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Severe",
"        <sup>",
"         &sect;",
"        </sup>",
"        (decompensated)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Liver tumors",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"13\">",
"        a. Benign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        i. Focal nodular hyperplasia",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        ii. Hepatocellular adenoma",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        b. Malignant",
"        <sup>",
"         &sect;",
"        </sup>",
"        (hepatoma)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Anemias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Thalassemia",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Sickle cell disease",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        <strong>",
"         Iron-deficiency anemia",
"        </strong>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Solid organ transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Solid organ transplantation",
"        </strong>",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Complicated: graft failure (acute or chronic), rejection, cardiac allograft vasculopathy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        4",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent2\">",
"        b. Uncomplicated",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Drug interactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"9\">",
"        <strong>",
"         Antiretroviral therapy",
"        </strong>",
"        (see appendix M)",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"       <td class=\"centered\">",
"        Initiation",
"       </td>",
"       <td class=\"centered\">",
"        Continuation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Nucleoside reverse transcriptase inhibitors (NRTIs)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Ritonavir-boosted protease inhibitors",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"       <td class=\"centered\">",
"        2/3*",
"       </td>",
"       <td class=\"centered\">",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Anticonvulsant therapy",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Certain anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Lamotrigine",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"13\">",
"        <strong>",
"         Antimicrobial therapy",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        a. Broad-spectrum antibiotics",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        b. Antifungals",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        c. Antiparasitics",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        d. Rifampicin or rifabutin therapy",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        3*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        2*",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"       <td class=\"centered\" colspan=\"2\">",
"        1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     COC: combined oral contraceptive; P: combined hormonal contraceptive patch; R: combined hormonal vaginal ring; POP: progestin-only pill; DMPA: depot medroxyprogesterone acetate; IUD: intrauterine device; LNG-IUD: levonorgestrel-releasing IUD; Cu-IUD: copper IUD; BMI: body mass index (weight [kg]/height [m",
"     <sup>",
"      2",
"     </sup>",
"     ]); DVT: deep venous thrombosis; VTE: venous thromboembolism; CHC: combined hormonal contraceptive; PE: pulmonary embolism; hCG: human chorionic gonadotropin; PID: pelvic inflammatory disease; STI: sexually transmitted infection; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome; NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase.",
"     <br/>",
"     * Consult the appendix for this contraceptive method for a clarification to this classification.",
"     <br/>",
"     &Delta; Clarification: For women with other risk factors for VTE, these risk factors might increase the classification to a \"4\"; for example, smoking, deep venous thrombosis/pulmonary embolism, known thrombogenic mutations, and peripartum cardiomyopathy.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     The breastfeeding recommendations are divided by month in",
"     <em>",
"      US Medical Eligibility Criteria for Contraceptive Use, 2010",
"     </em>",
"     . They have been divided by days for purposes of integration with the postpartum recommendations.",
"     <br/>",
"     &sect; Condition that exposes a woman to increased risk as a result of unintended pregnancy.",
"     <br/>",
"     &yen; Some studies suggest that women using progestin-only injectable contraception might be at increased risk for HIV acquisition; other studies do not show this association. CDC reviewed all available evidence and agreed that the data were not sufficiently conclusive to change current guidance. However, because of the inconclusive nature of the body of evidence on possible increased risk for HIV acquisition, women using progestin-only injectable contraception should be strongly advised to also always use condoms (male or female) and take other HIV preventive measures.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised Recommendations for the Use of Contraceptive Methods During the Postpartum Period. MMWR Morb Mortal Wkly Rep 2011; 60:878.",
"      </li>",
"      <li>",
"       Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection or Infected with HIV. MMWR Morb Mortal Wkly Rep 2012; 61:449.",
"      </li>",
"     </ol>",
"     <br/>",
"     Reproduced with permission from: US Medical Eligibility Criteria for Contraceptive Use 2010, with data adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12506=[""].join("\n");
var outline_f12_13_12506=null;
var title_f12_13_12507="Cytokines in rheumatic diseases";
var content_f12_13_12507=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F55029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F55029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cytokines implicated in rheumatic diseases",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Rheumatoid arthritis (macrophage and fibroblast cytokines)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IL-1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High TNF-alpha",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chemokines (eg, IL-8)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth factors (eg, TGF-beta, PDGF)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low TNF-alpha",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acid labile IFN-alpha",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IFN-gamma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IL-6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth factors (eg, TGF-beta, PDGF, FGF)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IL-6",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12507=[""].join("\n");
var outline_f12_13_12507=null;
var title_f12_13_12508="Evolution WHO terminology for neuroendocrine tumors in GI tract";
var content_f12_13_12508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74648&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74648&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evolution in WHO terminology for neuroendocrine tumors of the digestive tract",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        WHO 1980",
"       </td>",
"       <td class=\"subtitle1\">",
"        WHO 2000",
"       </td>",
"       <td class=\"subtitle1\">",
"        WHO 2010",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        I. Carcinoid",
"       </td>",
"       <td>",
"        1. Well-differentiated endocrine tumor (WDET)*",
"       </td>",
"       <td>",
"        1. Neuroendocrine tumor grade 1 (G1) (carcinoid)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Well-differentiated endocrine carcinoma (WDEC)*",
"       </td>",
"       <td>",
"        2. Neuroendocrine tumor grade 2 (G2)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Poorly differentiated endocrine carcinoma/small cell carcinoma (PDEC)",
"       </td>",
"       <td>",
"        3. Neuroendocrine carcinoma (large cell or small cell type)",
"        <sup>",
"         &bull;",
"        </sup>",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        II. Mucocarcinoid",
"       </td>",
"       <td rowspan=\"2\">",
"        4. Mixed exocrine-endocrine carcinoma (MEEC)",
"       </td>",
"       <td rowspan=\"2\">",
"        4. Mixed adenoneuroendocrine carcinoma (MANEC)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        III. Mixed forms carcinoid adenocarcinoma",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        IV. Pseudotumor lesions",
"       </td>",
"       <td>",
"        5. Tumor-like lesions (TLL)",
"       </td>",
"       <td>",
"        5. Hyperplastic and preneoplastic lesions",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The difference between WDET and WDEC was defined according to staging features in the WHO 2000 classification. G2 NET does not necessarily translate into WDEC of the WHO 2000 classification.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Definition in parentheses for the International Classification of Diseases for Oncology (ICD-O) coding.",
"     <br/>",
"     &Delta; The term \"Neuroendocrine tumor grade 3 (G3)\" has been used for this category but is not advised, since neuroendocrine tumors are by definition well-differentiated.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: WHO Classification of Tumours of the Digestive System, 4th edition, Bosman FT, Hruban RH, Theise ND (Eds), IARC Press, Lyon 2010. Copyright &copy; 2010 IARC Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12508=[""].join("\n");
var outline_f12_13_12508=null;
var title_f12_13_12509="Anaerobic bacteria in lung infx";
var content_f12_13_12509=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Bacteriology of anaerobic infections of the lung",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Earlier series&bull;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Later series&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Period reviewed",
"       </td>",
"       <td>",
"        1968-1975",
"       </td>",
"       <td>",
"        1976-1991",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Number of cases",
"       </td>",
"       <td>",
"        193",
"       </td>",
"       <td>",
"        110",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total anaerobic isolates",
"       </td>",
"       <td>",
"        461",
"       </td>",
"       <td>",
"        404",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Average anaerobic isolates per case",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\" rowspan=\"1\">",
"        Number of isolates*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Gram negative bacilli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fusobacterium nucleatum",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\" rowspan=\"1\">",
"        Former",
"Bacteroides species",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        B. fragilis group",
"       </td>",
"       <td class=\"sublist_other\">",
"        38",
"       </td>",
"       <td class=\"sublist_other\">",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Pigmented Prevotella",
"       </td>",
"       <td class=\"sublist_other\">",
"        76",
"       </td>",
"       <td class=\"sublist_other\">",
"        63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Nonpigmented Prevotella",
"       </td>",
"       <td class=\"sublist_other\">",
"        -",
"       </td>",
"       <td class=\"sublist_other\">",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        B. ureolyticus",
"       </td>",
"       <td class=\"sublist_other\">",
"        -",
"       </td>",
"       <td class=\"sublist_other\">",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Other",
"       </td>",
"       <td class=\"sublist_other\">",
"        37",
"       </td>",
"       <td class=\"sublist_other\">",
"        38",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Peptostreptococci",
"       </td>",
"       <td>",
"        87",
"       </td>",
"       <td>",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Peptococci",
"       </td>",
"       <td>",
"        39",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Gram positive bacilli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clostridium species",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eubacterium species",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Actinomyces",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        19",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lactobacillus species",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Propionibacterium species",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bifidobacterium species",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Veillonella",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Differences in the two series partially reflect, taxonomic changes and variations in microbiologic methods. In the earlier series, the \"black pigmented Bacteroides species\" were reported as B. melaninogenicus, whereas the later series reported these according to reclassification as Prevotella melaninogenicus, P. intermedia, and P. asaccharolytica. For gram-positive cocci, the clinically important organisms formerly classified as Peptococcus have nearly all been reclassified as Peptostreptococcus.",
"    </div>",
"    <div class=\"reference\">",
"     &bull; Bartlett, JG. Clin Infect Dis 1993; 16(Suppl 4):S248.",
"     <br>",
"      &Delta; Marina, M et al. Clin Infect Dis 1993; 16(Suppl 4):S256.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12509=[""].join("\n");
var outline_f12_13_12509=null;
var title_f12_13_12510="Glucocorticoid-induced osteoporosis";
var content_f12_13_12510=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Glucocorticoid-induced osteoporosis: Mechanisms of bone loss",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 388px; background-image: url(data:image/gif;base64,R0lGODlh7wGEAdUAAP///4CAgEBAQMDAwAAAANDQ0DAwMPDw8ODg4KCgoICZzGBgYFBQULCwsCAgIEBms8DN5nBwcJCQkAAzmRAQENDZ7FBzueDm8/9AQP+AgP/AwDBZrPDz+WCAv6Cz2XCNxiBNppCm07DA3//Q0P9QUBBAn/8wMP/w8P/g4P+wsP9gYP+goP+QkP9wcP8gIP8AAP8QEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADvAYQBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzM1+AwHR0tPU1dbX2Nna29zd3t/g4dwDzuVYAQLi6uvs7e7v8NHp5vRU0fVk9/j7Tfr8X/7+CSwScKCWggYFIkxoZSFDfA4fSokosRzFik4uYlymcaOSjh6PgQxpZCTJYSZPCkmp8hdLNCMyZEghZMUKMyNOMMlJpMUI/zwvW/IKWkYFCQ0aWpAAIFMMBg1CfDKROuQp0ABCnREds2LpEJ1NMwhBKiQDBhU/V5xFISQFBhI0NZA4WhZFBg0uVIhdwXYECQwsAKBQgeEmAL4A5JJwAfXO1qy3HoeBa6Tpi7JiW6gAMCJF1xN4AaQwcQIFXxcoUKAG8AJDhhEmWEB9qjpnYMYnSNykbQLFCRON7UiGTGv4F6sjMGBowVTs5eYAYOgUQhcABr80hbAQyzTwc+uNn7JgLiT52KXiyVt1jJW4MuNeVAQeiwH6c8tE1j9dD91+1fAaNEXfgE8JyF8d8Ln3SoJcoADDT4nV15R0AOhlnWEjjAfACS4wtf8ZZ7AJcR1rVWX3VGicRQdWYE+5JQRwVymYDINcyKVcYdCx4MJbYiWnXAonqGCCCTQFaYJrTA3J3Xej1WdVBkcuNZoJKuhkVQtUwsiejMjQOJCXXKIC5j9jhllKmfugaaYoatbT5pqfvGmOnHByQqdW7dUJzJ3N8KnnJX5ylOefvQT63qCE7oJOPIw2Oo0A6TgqqaPzJNoLNJNm2g6kmnbqDjmWhtqFoaKWugippqZqCKqqthoIq67Gygessta6pa24jkJrrry6sWuvwKbxa7DE5oNosZV4quyyzDaLzQILOCvttNSKg8Api1ar7bbcduvtt99WeuaxgAx7DrmYmJv/hbpEsPuGu/2gWwi8ZdBrj7xy2LuGvknw+4S/YAD8L75xCGyGwe0SLAjCXDC8BL0OixFxxEdQfO4jECu8ycQal9txJBZX/DEbIXvBcSMlV5FywnusvMXJjLg80ch/ZIwtzQji3LLOMfO888+mwHyqz4rIDIDNQRMNh8tGQ2E00uOuqrRwUx/ydNUSY42y1vtyXbDXC4P9NdBRzyu2r2f34QABbBNAwdZkkyI0Imu3/bYmC7RNAANw69H0FXMfknfbfGuSgN4S9J3H3w2lXa/jaRzeduKaIKB3AYrHmLTUi1jeNuabGMC2A45ALTfkY6wsOgGkcxIB2wuUjjrgs4fN//kirxMQOycNsJ2A7HHrWnvAw5fROwG/d8L2tZnfWjYhLi/viQAGYFz8FIyrfP2o249BfZwRWB88m92/XH4YAYTvSQENiO/3+e/fvgj7ZpouvPzIvgt/vDfjn38b9iOf//7XtfGFgmF1Y9vdCJiGBLptcfvTnCAGx7bCwYF5RkCABAKQgAMcIQKgI0IBPEiHAZgQgwcIIRkQgEFAUHBvEOzfICTHNsot7QgNMEACoGFBIggAVEQAYR0IEA0GCMCDBVDfEwgQBX0kIHmBoCEBbEg1GQrCc2xToa+OQAEUAiABnBLCDwFQACMmLgEsTB4av9gABjDgAOigohiYKAQwAv8AAb8z4RMB0AABMAB0fWRAAwZARCh+MYwAOMACBBCBA3AKASa84yLV2EYGtHAOWCSAFumQvXsVYnWtK5gRBlC9IgzAgwz43Q8R4IARJu6HAxCAGMnByANIwACndMAlwUBHIbQylkejQAQS0MYDsPIAOTQmGgkwABWeEgCpBIAO+VgAaJ3yHg44ZTRrKYHd2QGU8dscIXLnzRuaUpZFQAA6HICVH0pAiQCAJTrHOEZgxhOIc/ShCWWpDwZEKwDZFCQRejkEdQqAnQUo5UraE40CoHMAfKsnOu1AznA+TxDHM+S7MrhAIbCyfff4YUDkOct7AsCeYyQDQR1wAGDqQwD/EjDhKVMqBILe0QEgDYA9F7pQewJTonjIqEVPZwjpxaEAAUAACYdQqQPssJTRuucAWoe5HyY0kbg0KUrxGYZeLiB8LmVo4YwZgN1hjgBLPSlUA3CALiZSneq7BwU8GIBXkmOndjCqBIlaiO/JoZvwFIIiDQCpxC2AsAxoJzkCgFiTMsAAj6XlXefJVV5CygDtCesQIkBYAyj1sPNgLDxBm1g+ElYALCQsUrGSQwMswINAxYNfYyhO6AXWDW2NoEHSZ0BQRIx+cxBir4BL24syMEydxJ5ujxuM5M6sFxPlQmX1kEQzyLK6uXBuE5e7CJtaoZfR5QNe8zneWmjXadwd/yek2gcA5DFSCH0UQPvgmA4P6hGNCUBHHgt5tDoKYAHXwmMcywBRBoAqAH0sp1r1K4QCHzjBQ0DHa4tQRpiS0YjsZSIwK5zeV3U4XxFMYQYxOMJ07nIN89Vle8nBAAkUgKV4BEBUyxrMYU51hK20XDPb+8U3TvWk2TyAisXAShaqGHnQNORUlZpjXRa5vb+LZgRYG11WuhIBnnUkOTQsSwq4Egwn5mNDEXHegcEhAaGMcJ5oWkeNsmEAERAABbbcYNRSIKZCWODb9GHPe/SSiQYWYwG2OoYNriRxdAxIn+vKUETzlALSIOg7hyCBSM2DywBwQASeCZAPGhiM0/WYFf/bwFmu+mOMCShATCNJTDcyT8JpBUMOq0rnk8pSnYTlcU2Plll0+nkITEwpSU2aNZ4melCL1seveb1imbJsJQuQ6bUwbUsGzLXTRiCoBxVZqVTHdI0xFrAAUu1qAH54bLjNrxxPTUt2YiqejewmAKbMx/ACJHwHyCodIyABFiYS0O2DKLNtLQQDnJWETJy0kAlO7DBcNZ5n5ekQ7Gnwhwsg4sy2MBmJ8GMyTpWEEQcmqLJqsiP4sQEYzCq9D6pToE41l2yVN8nOvTTdHovdxA7pZAEA6Wh41wv59qO+qfdaLFPvdw6FFOb4TAHqMdQA4WPiYA0QcMrmwwCY3fXAG9z/9KwfDevtOXYiHwtZgjQ2AZ1tH6bJftuDHKHaDjBACtlZVlkKe+eELu8ZypwRm5dkzZLlKVCZ6ew/6D1NS4gWKWVK65KK3OqHf9yoAThKdLYVtgdWLME1vkk9RJ4eSFVqEWyYyraCrvHQbJ8d827vvdNcf6IsSdpLmvGdH4DsPWTu6L9qhAU4wOlCSCjwUzrV/8qS9eaePMlsZa7cToLv/Dsz888tXJC9Hm26L7aglG+R60t++7WtA3aJIGJJQP/Zh+J+HMo7fkicX81r+PzEW3+Enw/1fgD8bwEQsMg/MlzC+/c7mUUO4kZuljQI7ydxwuJu9eZ/HHY0DAhGAJZI/4v0WoTEQRcmXyuhTiw0SXVUSa/2X7FmMt43c6QWO+yDAJjzYgQXASg4SLIkdi8nZDGnYH6QgFuHBmg3AAhQTMfkZbb0RbiERz5GOi1GTTq2f1k2RgSQDqykTaoUb7FDb32UOiVYQGxwbUOQAIuEaVpIcDIIefTXW4DSPfbkT9GQTZr2TGcIKhe3AILEPHRUafKAFXTkUA0WUTvXcwFgf+ajfmVAUC44bWDIcTHIU8hnO57gJyi1aqdUbXNFaCbFhXOma2UlbbrmU3a3c4QXSWDgQB11QOczbsGngZazeckzaF3mQVGViB4WJ2ZYSgEwVpBUcCZUSgpHOqBCb2gFZP8gp2s8R1d2tXmU03la8EK55wmguAZJJ18vxkiY1owwCAAS8Hul5YqitojlAym/w1nUgwBsJ0bjNnUgdVp0BXVCSD1qNwStNWFAdXtYl4xbIEVy5AnICBFXqH3IkEnGuAn0iI+wuAzgNAr8CJDauAwVRQoD6Sb5iD4NyQhCRQoJyZABuQx6JQoRSZEHuQyzRQoXWTMPaWYb+R5tBwodmY3Nowk42AbEJTclOSsh2XcVmX1e0JIo2TMziZM0qVzu0wlXs5M8CTwjqZNAiV49aScxGX1FKZIpmQk/uQsHMIJkFA3slZNDY5VFMzsnxoMTF2ZKMIZvVlk51AANEFVpwGb/NXeUG5OUTNAm5NKEDUZEUuCHYWkENEVCsPZFqjYA4JY8CFZLi8RV3NYe8YVyDhBV3nZN9ZVI6DBM8OVHmCNu9bhdaqmSbPkws/OW0SZjM9Zg5MBtExZI69iA/WgGntguOhRCVGh37hZbSOZqLEgEKhcAL6ZM+YZnLDcAMzaFWGFHPshSMzhkniSUPnmZH5GZ9VdG4Lhs93CEDcA+chdjTPSbUnkGp0kEXGgAXsZzkUZsrilxBPVi0bBICHBnbnieeTYEb3NtwISGALVPtDecTZkuxtkvyJlt8SRSdshTcIhyqTdQ0PRP2eQG12kEdtSJgadV6CR2wKhWjHdHjLWJ/7T3Z5lod47YUlanPY2wjEhZmdhWBJjGnO1BibGET8F2oSxpQlrUQUIgb5xHbAJlR5YYduS3nWTkbwcQbOyVUgIlcFlVhbMoWJCUofKpCPfYocQJBmS1SQQlV6yIFbs4nsHHY0H6ViwJLVpUjUS3bbhHbMW3SFqnDzYlfJhldNOUQxJKRpBycWQEWUYkBN7oWZJYpInwj0g6n1zggvXYpFihpaUVoUc0WJcGp53llWUAKYRAQlxohY1QkHdKlOjzhZKwRzP0e0fEqI2wkGvpoV3Qfq4iMxO5qUm6lG1ZnzjkO0N5lclAqY/aXQRgqJTwlIXgqTAJok6AlkjgLkZzkv+WyalhgKtTQEfydwZxpoFHA2GShEhxiYEVxl7o8EesFFX8R4r1poGPNJh1tJf0xVZ3lF+ch2ENY6oV85KWIKvoA5nRihVJlVRHI4JsVG6H1IqFFEsD5gYpNm1R9jtZZZYexUxKqFTuxDfsc5vkEGSpVJsxZk35Rg4r5267CWS5lFoAG2pB2Qg22auj6gUSILANQLDt5YSrCW+2FDs+yERJGJywOgZwJme11lCyiChzaGkclJolhYcnZUnmyVPiWXfEpmcM504y+4fIJa5/NwZol2oTqp7dCVQCpWvCSqRqMGsmdWyLZqtHE20ndFIRwE4KWmcQmmv3sHgqSmwUulX/l5i1B0G04aeqYgBnXJtSfyZTgfdToEJHTxufasBbCzujlzdvMGtfLBV8JVaFxnptdYWjTKS3Nop6Pco3W/VxU5q29aO26AcGg2t3GcZUxdi19JajNWVfUJsGQRdZMyqEboQoopWOVIemBmdastSOxtRZv2N0BUCmmqemSvez5IB26ii0XGKuX8C6mIOmwAiPZfeOkPI6KwF1c5oQK+l+lAt/fEBCrJQVz+urA3QHz9i6QgEwUXkEq1WVvhW9CkiqpQoIBWpaZMmvWJkI19slD5m+d7kS7pqYfbkSfdRIgUlm5JuD5nuc6FtZjIW0cEpl8dSaOwdl0GRJsZm9/Pu//0rZB+n7RYe1nXwYbOhpTwxKlzfYv7rav+OLBhTQYqWpBBO8hTEot96ZwBv8wBk7B+8LqSrVNoe5Rk4waDuGnSTkopvLo6q3oODpwniallzCf82iN3oDdeKLBNW0AFn6e67FpfHopb8HpqXboNDjwa8XwwRxmc6CxG2TDiUsjq4AvJwEwuuCxl2QxBGwxEzAqqtgxjCsxrTjCjWcsrggxyCWClxMD3qMboB4DNU3BCUmqkMMe2JCx32Aq4NMn9iLyIG8CxV2Rog0RpP8RWlUR9fSam9Ur2wrw2fMx4p8Qa0UhM+0TTxYynZFaNyES0KGxyD5yNiXyMQwaQW1Toply/+zxMoJDKxmI8vJR8sokScfVXsjBZ8mFVu+nMXAbILCLAwdN2hrJVVUdU9XtbfKTLEIqMXFtbZ70likpXkRqofQBFlZlc2g7L5bPMp0CsEVm857/Mzu3M7q3M3GNc+U+cLxHMnpl6pZac98ZZDF2cxYyM8zws72SdB5i9DPlSYMLTIKLSwPbZQO3b5CXEXy7McT3cURjQZ9LL0C3ar/vFf33H0WbTXrLMr8gIN/TMQGDb8n7cCA7M0m7c/1TNIBrZEDrc8zXdJ4EtO/jNP4F9KGDM89ndMaDdTMLNQCVA8cWtSfnDMqXQ9HCtUj7Tw0zQx2atU3jdU+vQyOytUXLdX/GV0OmoqxhzzLL20MoYrWRu3SWc0MGSnWKA3QQ10PH+mU3MzUosgPvKrXHe16Uw0R5Jose+3VSG0OFwvYPA3XX43P59vYkBzXkI2ZgX0wGy2Tld3QaR3Ma73ZIP3Wk/3Yr+BvRhC+lpu1OCxTKURC5Verkq3WlP0K0GIEY1mWYvNfA5xfvhcNCEB8YBnKse3Zs90KjnSp+jQEeFm/e3m/xwqYaDlGnstwXhrcc3zZ3/fZqNAAT7TEA6yaBpybrhllDJxmJlWeXitG/2TFsN3ZzqzdqDDB2WnBS5vBQDxwNqXbDpA8OwVTJlRpHYzdxjLYtnDC/tVskXR3DNfCPhRT/0vV36AyrPss2rJN2q6QvixKjbHzoj58SGFKo8ltiEwV4dY94VEt3PB9CumrpVE8dlNMfFV832JaBGgJ4end3hRO3BbeCgYuCy092ok9C7WrKIeN0Sle2T9e4UEO2gA83O9d3Aet1Nts101N1G594tdd1jW90+5d0FAO0zY91ij+5SKR2aGN5Sa+5H1i5uWL5kd910kd5nXN1yFc0XIu046t5szA0kVO1kfeXGzuv1dt5GRuDHwu4Jj653sS6Emu43oOflye40++42Ae6W6e53A+J4ze52NO6WUu5YqI2Jm+5SLd1YQ+Ck+t6Z2Q6ofA6nDg6p9Q1arOCbIuOHojj/9uUOugsNXOAOuUwOuHAOxnhjilENbOoOuVYOyHoOwXdDmmcNbNIOyWAO2HQO1wYO2f0NbNwOyWoO2H4O1wAO6fMNdmPTqdQO6IgO5xoO6hkNfNIO6V4O6HIO9wQO+f8NfNwO6WgO+HwO9w4O/gww/2HquFbVuLU/CdsNjOAPCUoPCH4PBwAPFM7jQIP/EWHwUSf/Eav/Ec3/Ee//EgH/IiP/IkX/Imf/Ion/J1ging0vIu3w7a3AYs//I0X/PjAD2RYvM6v/PSIC6clPM8H/Q07/M3CSfq8tGI7uiTK+pDu9R6cvSBXoZOXydQTygMg/ROLtFWz5ZY3+UeHfXlyvX/YG/YTP+7Yr/1ZS8jVz/2sXpuXS/pp84GEHAEFQABEFABfMABeH9/ac4GF0D3dr/3V1ABFvAAXnABf0+Gim8GFzABiU8ED9ABCmABFoAHEyAEFfABiz/pbaAARxD5k1/5VwACFcABWgABhg8AHuABOF70a6AAkm8EDzD3AHD5AAABlE/7CiACkT8EChD5pk8ECnABw88BHfAAng8Av28BeH8Bx8/6tw8Bq38BHvD7rA8BE6AAHkD9AMABv68Apk/9vx8CQP7mr//5tG/7zv8A0O8BIkD5if/7HRD8QoD92u/9yB/+HgABng8ECtHjw+k8IIDL0VIBKEAKyFR59AAA/xDRMYn1fsFh8ZjsDQTKafWaPT634fGQIhR+hCCKjxJ0ufQBJq4srj4UAIbAJh4ULjaSDEMsACpEAEAgOAifSj48IEAqOEIvJiAqIB4AOg4VOrIwRy/iaNPeanHbbnN5wQ7t8PSwYjeJOEJeDRFVvUpPWZ9eIUosDgUBLCwuKkCUnLgBPB4vFA6JrxQetrt723fb4eHe42t/wR5YPzYu5rDoAv0dKlFOwQRFWLiVs7LBwzdmECaVw5IqIMAsqkp4yUgRABJ6teZ95BVSZBt7X/Dp2Vfh4SSPFAeWM/hlZkYsG5lZlGjRwxGDHMuxnBjx18yS8tAcVfqF5FIyJ714BP9gaKfEmVanUKE58dEUJxA+ROFIcSdQaxNVGf3JTKrTMk3dqoEb15cYqYbGqnqZNmsXLzPVXvxbEeCHDrPWBsz7pChdW0kdf5wbGSoWqYQqbLDs5OqhOwgPAuBQwgklUcsAlODwpE5ZZhs4r6ZowRJEwR39RmYKWbdc3r2/VGi0GmWXTapZ4xb8mVJo2lkmcdTZ+IGlUlk0M069+t9Oo8DN/AaPa7Ljyh03PNiw58mGDY21a3I/aSvC9O9F3HeSf0MH7r+mUe8XBdajiKUHHviKrdyAKw88B+NChj2U7mOPP/+Uo0i+DegbjBIEE7xtOiwM4oaImRD0QKIL/yNxvN3/XuwFQrfOi3EM6WwESbwcAZjRqdFq5FFIGXcc8q0ie7vCyBtzWnINHyODcqkPSnPSSh2v9C3LLbl0A8kYpexSzAe/3DLMMdF07Ey31kzTTaXaBLPMN+lUc04y68zzxTj3vFPPPyXzszc+AS30SUGXJNTQRb20UlFGIQ2vzkcjhZRSei6t1NBM7dTU01w4dQfRT0ntcdQhAxDgjFVZbdXVV2GNVdZZaa3V1ltxzVVXWlV1VNVdgQ1W2GGJLdbYVE8VcoBjmW3W2WehfXUAK5eN1tprsc0W1mlL7dbbb8ENV9xxyS3X3HPRTVfdddltN9FkGQ3V3XnpdRTeReWtV999//s8N19+AQ6YzXs3JVjggxHu1Nx/E27YYaT8NfjhiSnGcmGJK85YYzIY5rLjjUE++OMsRw7ZZH1LtvfklVnW8uKWYY5Z0pdlrnnllJ3E2eadSdXZSJ95DtpSjPUEWuijATWaR6WRbvpNpm2E2umpu5S6X6qxptfq8bbO2msbHSBAbAIoGDfsscv+Wm1yFxibAAbGbXtsuNeuG9wE3JZgXLzH1tvuv0tFwO0CxhV8bMIBT9xTA8R2oFzGCXBc8ckjjUDsBcq1nADMKe/c0AbETqBc0AkQ3fPT/xQbAXNVR931OgUw4NzYX6/dzQAi8Dd323nvsoAGzv299+GJL9744/+RT1755Zlv3vnnoY9e+umpr97667HPXvvtue8++mq1DV/88Ynl1vuAkSVf/fXZf7XX89EnOvGu4SdZfsDpr19l5/PX/93n++c/VN3vbwEU4NIIaDcDHjBqCazbAhl4teZBMIJ44p8DK/in/s0iDKg4BV2alDQMZjBP/TtPSrIRl++IkITsMqFdujCTJTxASR4QQTY4mA4MeUEEXdACdCwQwyx0YUBDKAIXsDCEJuRshC18WhN5ccJgsOccHSkCMqZyiER4wQP0IcQf/AAIg3iHRIPQBjhuyIE/EGeATlTXC+2Qj5W0JEMYIcgKSxBGAPQjOWOET2dcZAFWQIFBOaL2oBvjAsd7dAEvD9FLEihiiqz4gg6tGNBZyDgigNwhK2wU0iER6ZT8CecCnlQONq6AnH/spSN1aM4X/gCIzGwGICHYw3U0OUb6qPF/oaTZkiRkhwol0T0YYuWGOuQFQXqBQO9x0ShO5CLtWEQf6uFgG31ZrvwBCWSgzGZJ+kelbkLxm/YDIDnLub8JojOdvVxnO8PlzYnJE55EOmc9v0VPh+kTnxZ7Zz9Llb72DZSg4XsfQD8FvoIulKHPMh9CIRpRiU6UohW16EUxmlGNbpSjHfXoR0EaUpGOlKQlNelJUZpSla6UpS116UthGlOZzpSmNbVpP4MAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the mechanisms of bone loss in patients with glucocorticoid-induced osteoporosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Libanati, CS, Baylink, DJ, Chest 1992; 102:1426.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12510=[""].join("\n");
var outline_f12_13_12510=null;
var title_f12_13_12511="Midshaft clavicle fracture with shortening";
var content_f12_13_12511=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Midshaft clavicle fracture with shortening",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 182px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain radiograph shows complete displacement of a middle-third fracture of the left clavicle, with marked shortening (over 4 cm). Patients with&nbsp;severe fracture&nbsp;displacement have better outcomes with operative treatment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Hatch, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_13_12511=[""].join("\n");
var outline_f12_13_12511=null;
